<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="EN" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Agric Food Chem</journal-id><journal-id journal-id-type="iso-abbrev">J Agric Food Chem</journal-id><journal-id journal-id-type="pmc-domain-id">822</journal-id><journal-id journal-id-type="pmc-domain">acssd</journal-id><journal-id journal-id-type="publisher-id">jf</journal-id><journal-title-group><journal-title>Journal of Agricultural and Food Chemistry</journal-title></journal-title-group><issn pub-type="ppub">0021-8561</issn><issn pub-type="epub">1520-5118</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>ACS AuthorChoice</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11066870</article-id><article-id pub-id-type="pmcid-ver">PMC11066870.1</article-id><article-id pub-id-type="pmcaid">11066870</article-id><article-id pub-id-type="pmcaiid">11066870</article-id><article-id pub-id-type="pmid">38629896</article-id><article-id pub-id-type="doi">10.1021/acs.jafc.3c06309</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>Analysis of Lemon
Verbena Polyphenol Metabolome and
Its Correlation with Oxidative Stress under Glucotoxic Conditions
in Adipocyte</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name name-style="western"><surname>Olivares-Vicente</surname><given-names initials="M">Maril&#243;</given-names></name><xref rid="aff1" ref-type="aff">&#8224;</xref></contrib><contrib contrib-type="author" id="ath2"><name name-style="western"><surname>S&#225;nchez-Marzo</surname><given-names initials="N">Noelia</given-names></name><xref rid="aff1" ref-type="aff">&#8224;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath3"><name name-style="western"><surname>Herranz-L&#243;pez</surname><given-names initials="M">Mar&#237;a</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#8224;</xref><xref rid="notes4" ref-type="notes">&#167;</xref></contrib><contrib contrib-type="author" id="ath4"><name name-style="western"><surname>Micol</surname><given-names initials="V">Vicente</given-names></name><xref rid="aff1" ref-type="aff">&#8224;</xref><xref rid="aff2" ref-type="aff">&#8225;</xref><xref rid="notes4" ref-type="notes">&#167;</xref></contrib><aff id="aff1"><label>&#8224;</label>Instituto
de Investigaci&#243;n, Desarrollo e Innovaci&#243;n en Biotecnolog&#237;a
Sanitaria de Elche, <institution>Universidad Miguel Hern&#225;ndez
(UMH)</institution>, Elche 03202, <country>Spain</country></aff><aff id="aff2"><label>&#8225;</label>CIBER:
CB12/03/30038, Fisiopatolog&#237;a de la Obesidad y la Nutrici&#243;n,
CIBERobn, <institution>Instituto de Salud Carlos III
(ISCIII)</institution>, Madrid 28029, <country>Spain</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Email: <email>mherranz@umh.es</email>.</corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>04</month><year>2024</year></pub-date><pub-date pub-type="collection"><day>01</day><month>05</month><year>2024</year></pub-date><volume>72</volume><issue>17</issue><issue-id pub-id-type="pmc-issue-id">461626</issue-id><fpage>9768</fpage><lpage>9781</lpage><history><date date-type="received"><day>17</day><month>11</month><year>2023</year></date><date date-type="accepted"><day>26</day><month>03</month><year>2024</year></date><date date-type="rev-recd"><day>21</day><month>03</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>03</day><month>05</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>04</day><month>05</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-05-04 10:25:29.990"><day>04</day><month>05</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2024 The Authors. Published by American Chemical Society</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Authors</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jf3c06309.pdf"/><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="ab-tgr1" position="float" orientation="portrait" xlink:href="jf3c06309_0010.jpg"/></p><p>Lemon verbena has been shown to ameliorate obesity-related
oxidative
stress, but the intracellular final effectors underlying its antioxidant
activity are still unknown. The purpose of this study was to correlate
the antioxidant capacity of plasma metabolites of lemon verbena (verbascoside,
isoverbascoside, hydroxytyrosol, caffeic acid, ferulic acid, homoprotocatechuic
acid, and luteolin-7-diglucuronide) with their uptake and intracellular
metabolism in hypertrophic adipocytes under glucotoxic conditions.
To this end, intracellular ROS levels were measured, and the intracellular
metabolites were identified and quantified by high-performance liquid
chromatography with a diode array detector coupled to mass spectrometry
(HPLC-DAD-MS). The results showed that the plasma metabolites of lemon
verbena are absorbed by adipocytes and metabolized through phase II
reactions and that the intracellular appearance of these metabolites
correlates with the decrease in the level of glucotoxicity-induced
oxidative stress. It is postulated that the biotransformation and
accumulation of these metabolites in adipocytes contribute to the
long-term antioxidant activity of the extract.</p></abstract><kwd-group><kwd>cellular uptake</kwd><kwd>lemon verbena metabolite</kwd><kwd>adipocyte</kwd><kwd>oxidative stress</kwd><kwd>glucotoxicity</kwd><kwd>cellular metabolism</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>European Commission</institution><institution-id institution-id-type="doi">10.13039/501100000780</institution-id></institution-wrap></funding-source><award-id>NA</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Programa de Ayudas para la Investigaci??n del Envejecimiento de la Fundaci??n ICAR, call 2023</institution><institution-id institution-id-type="doi">NA</institution-id></institution-wrap></funding-source><award-id>PLANTAGING</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Conselleria de Innovaci??n, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana</institution><institution-id institution-id-type="doi">10.13039/501100016386</institution-id></institution-wrap></funding-source><award-id>PROMETEO/2021/059</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Centro de Investigaci??n Biom??dica en Red-Fisiopatolog??a de la Obesidad y Nutrici??n</institution><institution-id institution-id-type="doi">10.13039/501100012514</institution-id></institution-wrap></funding-source><award-id>CB12/03/30038</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Ministerio de Ciencia e Innovaci??n</institution><institution-id institution-id-type="doi">10.13039/501100004837</institution-id></institution-wrap></funding-source><award-id>PID2021-125188OB-C32</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>jf3c06309</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>jf3c06309</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p>Oxidative stress, defined
as an overproduction of reactive oxygen
species (ROS) in cells and tissues relative to antioxidant defense,
plays a pathogenic role in the development of several chronic inflammatory
diseases associated with obesity, such as insulin resistance, type
2 diabetes, and cardiovascular diseases.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> In this context, polyphenols from lemon verbena (<italic toggle="yes">Lippia citriodora</italic>), a digestive and anti-inflammatory
plant used in folk medicine, have been associated with enough evidence
to become an alternative way to alleviate the metabolic disturbances
associated with obesity.<sup><xref ref-type="bibr" rid="ref2">2</xref>&#8722;<xref ref-type="bibr" rid="ref4">4</xref></sup> Furthermore, several exercise
training trials have demonstrated the potential use of lemon verbena
extract as a nutraceutical to protect against oxidative damage and
muscular injury caused by intense physical activity.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup></p><p>The leaves of lemon verbena are rich in phenylpropanoids,
iridoid
glycosides, and flavonoids,<sup><xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref6">6</xref></sup> and the bioactivity
of this plant has primarily been attributed to its major component,
namely verbascoside (also known as acteoside). In addition to its
strong antioxidant power,<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> this phenylpropanoid
has been shown to exert anti-inflammatory and antilipogenic effects
in hypertrophic adipocytes by upregulating the anti-inflammatory adipokine
adiponectin and activating the energy sensor AMP-activated protein
kinase.<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> Despite this evidence, recent
studies evaluating isolated fractions of lemon verbena extract obtained
by semipreparative chromatography suggest that other compounds present
in the extract, such as its isomer isoverbascoside or the flavonoid
luteolin-7-diglucuronide, might also be potential contributors acting
synergistically in the bioactivity of this plant.<sup><xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref8">8</xref></sup></p><p>Furthermore, when evaluating the therapeutic effects of polyphenols,
their bioavailability and biotransformation events should be considered
to identify the most likely final effectors.<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> In this regard, a previous bioavailability study in rats shows that
verbascoside and isoverbascoside are the primary plasma metabolites
after the ingestion of lemon verbena, but other minor metabolites
have also been detected, such as phenylpropanoid derivatives (i.e.,
hydroxytyrosol, caffeic acid, ferulic acid, ferulic acid glucuronide,
and homoprotocatechuic acid), as well as other phenolic compounds,
iridoids, and flavone derivatives (i.e., luteolin-7-diglucuronide).<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> Although the accumulation of some of these metabolites
in target tissues, such as the brain, liver, and kidneys, has been
reported,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> their distribution and the
intracellular final effectors in adipose tissue are still unknown.</p><p>To address this gap in knowledge, the aim of this study was to
establish the antioxidant capacity of seven plasma metabolites of
lemon verbena (i.e., verbascoside, isoverbascoside, hydroxytyrosol,
ferulic acid, caffeic acid, homoprotocatechuic acid, and luteolin-7-diglucuronide)
in a cell model of hypertrophic adipocytes (molecular structures in <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). In addition to
being the most abundant plasma metabolites identified after lemon
verbena ingestion,<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> verbascoside and isoverbascoside
were selected for being potent antioxidant agents and modulating targets
involved in energy expenditure and inflammation.<sup><xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref4">4</xref></sup> Hydroxytyrosol,
ferulic acid, caffeic acid, and homoprotocatechuic acid were selected
as minor plasma metabolites of lemon verbena<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> but with strong antioxidant power.<sup><xref ref-type="bibr" rid="ref11">11</xref>&#8722;<xref ref-type="bibr" rid="ref13">13</xref></sup> Although little is known
about their role in adipocytes,<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> it is
postulated that they might be relevant effectors of verbascoside and
isoverbascoside since they are derived from the hydrolysis of these
phenylpropanoids. Finally, luteolin-7-diglucuronide represents the
only flavone derivative identified as a lemon verbena plasma metabolite
that has been reported to modulate targets related to energy metabolism
in adipocytes.<sup><xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref8">8</xref></sup></p><fig id="fig1" position="float" orientation="portrait"><label>Figure 1</label><caption><p>Molecular structure of seven plasma metabolites
from lemon verbena:
(a) verbascoside; (b) isoverbascoside; (c) hydroxytyrosol; (d) caffeic
acid; (e) ferulic acid; (f) homoprotocatechuic acid; and (g) luteolin-7-diglucuronide.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr2" position="float" orientation="portrait" xlink:href="jf3c06309_0001.jpg"/></fig><p>Furthermore, the correlation of the decrease in
intracellular ROS
levels with the uptake and intracellular metabolism of these metabolites
was addressed using high-performance liquid chromatography with a
diode array detector coupled to electrospray ion trap mass spectrometry
(HPLC-DAD-ESI-IT-MS). Using this experimental approach, we attempted
to demonstrate that the plasma metabolites of lemon verbena are absorbed
and metabolized by adipocytes through phase II reactions and that
the intracellular appearance of these metabolites correlates with
a decrease in glucotoxicity-associated oxidative stress in the cytoplasm.</p></sec><sec id="sec2"><label>2</label><title>Materials and Methods</title><sec id="sec2.1"><label>2.1</label><title>Chemicals and Reagents</title><p>Standard verbascoside,
hydroxytyrosol, and ferulic acid compounds were acquired from Extrasynthese
(Genay, France). Isoverbascoside and luteolin-7-diglucuronide were
purchased from PhytoLab (Vestenbergsgreuth, Germany). Caffeic acid
and homoprotocatechuic acid were obtained from Sigma-Aldrich (St.
Louis, MO, USA). Ethanol was provided by PanReac AppliChem GmbH (ITW
Reagents, Darmstadt, Germany). Methanol (HPLC-MS grade) and glacial
acetic acid were acquired from Fisher Scientific (Thermo Fisher Scientific,
Waltham, MA, USA) and Labkem (Labbox, Barcelona, Spain), respectively.
The water used in the HPLC-DAD-ESI-IT-MS analysis was purified using
a Milli-Q system from Millipore (Bedford, MA, USA). Dulbecco&#8217;s
modified Eagle&#8217;s medium (DMEM) and a mixture of penicillin/streptomycin
were acquired from Gibco (Thermo Fisher Scientific). Calf and fetal
bovine sera were obtained from Fisher Scientific. 3-Isobutyl-1-methylxanthine
(IBMX), dexamethasone, insulin, dimethyl sulfoxide (DMSO), and phosphate-buffered
saline (PBS) were provided by Sigma-Aldrich.</p></sec><sec id="sec2.2"><label>2.2</label><title>Model of Hypertrophic 3T3-L1 Adipocytes</title><p>The 3T3-L1 preadipocyte cell line (ATCC CL-173) was propagated
and maintained in DMEM supplemented with 10% bovine calf serum, 100
U/mL penicillin, and 100 &#956;g/mL streptomycin under optimal conditions
(37 &#176;C, 95% humidity, 5% CO<sub>2</sub>). Confluent preadipocytes
were differentiated into adipocytes by incubating them in DMEM containing
25 mM glucose and supplemented with 10% fetal bovine serum and adipogenic
agents (0.5 mM IBMX, 1 &#956;M dexamethasone, and 10 &#956;g/mL
insulin) for 48 h. Afterward, the cells were maintained in high glucose
DMEM supplemented with 10% fetal bovine serum and 10 &#956;g/mL insulin
for an additional 2 weeks. Under these glucotoxic conditions, nearly
all cells become hypertrophic adipocytes with high intracellular levels
of lipids and ROS, mainly as hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) content.<sup><xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref16">16</xref></sup> The oxidative status of this
cell model was evaluated as described in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Supporting Information</ext-link>. Subsequently, the hypertrophic adipocytes were
treated with the standard compounds at 25, 50, and 100 &#956;M for
24 h or with 100 &#956;M for 3, 12, and 24 h for the correlation
analysis. Previously, pure compounds were dissolved in DMSO or water,
depending on their solubilities, and reconstituted in culture medium
for sterilization. The amount of DMSO used for the cells did not exceed
0.1%.</p></sec><sec id="sec2.3"><label>2.3</label><title>Quantification of ROS Generation by H<sub>2</sub>DCFDA Staining</title><p>After treating the hypertrophic adipocytes
with lemon verbena metabolites, the intracellular ROS generation was
analyzed by incubating the H<sub>2</sub>O<sub>2</sub>-sensitive fluorogenic
dye 2&#8242;,7&#8242;-dichlorodihydrofluorescein diacetate (H<sub>2</sub>DCFDA, Sigma-Aldrich) at 40 &#956;M for 30 min at 37 &#176;C.
Then, the cells were washed with PBS, and the fluorescence was measured
at 495 nm excitation and 529 nm emission wavelengths using a cell
imaging multimode microplate reader (Cytation 3, BioTek Instruments,
Winooski, VT, USA). To dismiss any possible cytotoxic effect of the
compounds, the Hoechst 33342 dye (Invitrogen, Thermo Fisher Scientific)
was added at 4 &#956;M, and stained nuclei were counted by taking
microphotographs with a DAPI imaging filter cube.</p></sec><sec id="sec2.4"><label>2.4</label><title>Determination of MDA by HPLC with Fluorescence
Detection</title><p>Malondialdehyde (MDA) was measured as a marker
of lipid peroxidation in hypertrophic adipocytes treated with lemon
verbena metabolites at 100 &#956;M for 24 h.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> Briefly, the treated cells were washed and gathered with a scraper
in PBS. Pooled cells were lysed by three cycles of freezing and thawing
by sonication using an ice-cold bath sonicator and centrifuged at
16,000<italic toggle="yes">g</italic> for 15 min at 4 &#176;C to collect the supernatant
for MDA analysis. The protein concentration was analyzed by using
the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific). The supernatants
were mixed with 0.05% butylhydroxytoluene (Sigma-Aldrich) in 99% ethanol
to prevent oxidation reactions and 20% trichloroacetic acid (PanReac
AppliChem GmbH) in 0.6 M HCl (VWR Chemicals, Radnor, Pennsylvania,
USA) to precipitate protein. The mixtures were cooled on ice and centrifuged
at 2,300<italic toggle="yes">g</italic> for 15 min at 4 &#176;C. Then, the supernatants
were mixed with preheated 0.6% thiobarbituric acid (TBA, Sigma-Aldrich)
and heated at 97 &#176;C for 30 min. After cooling, the samples were
vigorously mixed with cooled <italic toggle="yes">n</italic>-butanol (Scharlab,
Barcelona, Spain) and centrifuged at 18,000<italic toggle="yes">g</italic> for
3 min at 4 &#176;C. The TBA-MDA complex contained in the upper phase
was analyzed by HPLC using a Merck-Hitachi LaChrom system equipped
with a model L-7485 fluorescence detector (Hitachi Instruments, Tokyo,
Japan). The separation was carried out with a LiChrospher 100 RP-18
column (5 &#956;m, 250 &#215; 4 mm) (Merck, Darmstadt, Germany) using
50 mM potassium dihydrogen phosphate buffer (Merck) and methanol (60:40,
v/v) as the mobile phase. The injection volume was 20 &#956;L and
the flow rate was 0.6 mL/min at room temperature. The TBA-MDA complex
was monitored by fluorescence detection, with excitation at 515 nm
and emission at 553 nm. The MDA content of the cell lysates was calculated
from a standard curve prepared using different concentrations of TBA-MDA
complex.</p></sec><sec id="sec2.5"><label>2.5</label><title>Sample Preparation for Metabolite Detection</title><p>After 0, 3, 12, and 24 h of incubation with 100 &#956;M lemon
verbena metabolites, the adipocytes were washed with PBS to remove
the remaining compound from the extracellular side and gathered under
cold ultrapure water. Pooled cells were lysed and centrifuged as mentioned
above to collect supernatant and precipitate fractions as cytoplasmic
and membrane fractions, respectively. The protein concentration in
the cell lysates was analyzed using the Pierce BCA Protein Assay Kit.
For HPLC analysis, the cytoplasmic and membrane fractions were subjected
to protein precipitation using methanol:ethanol (50:50, v/v) at a
proportion of 1:5 (sample&#8211;solvent), vortexed for 10 s, and
centrifuged at 17,900<italic toggle="yes">g</italic> for 10 min at 4 &#176;C. Lastly,
the supernatants were collected and evaporated under nitrogen gas,
dissolved in 120 &#956;L of methanol:water (80:20, v/v), and stored
at &#8722;80 &#176;C until analysis.</p></sec><sec id="sec2.6"><label>2.6</label><title>HPLC-DAD-ESI-IT-MS Instruments and Conditions</title><p>An Agilent LC 1100 series system (Agilent Technologies, Inc., Palo
Alto, CA, USA) equipped with a pump, autosampler, column oven, and
DAD was used for the HPLC analysis of the cytoplasmic and membrane
fractions. Aqueous acetic acid (0.5%, v/v) as solvent A and methanol
as solvent B composed the mobile phase to elute the samples from a
Poroshell 120 SB-C18 column (2.7 &#956;m, 4.6 mm &#215; 150 mm),
which was protected by an InfinityLab Poroshell 120 SB-C18 guard column
(2.7 &#956;m, 4.6 mm &#215; 5 mm). The following multistep linear
gradient was established: 0 min, 5% B; 5 min, 5% B; 10 min, 15% B;
16 min, 17% B; 22 min, 20% B; 30 min, 30% B; 38 min, 33% B; 45 min,
100% B; and 50 min, 5% B. The initial conditions were maintained for
5 min to equilibrate the column for the next analysis, as indicated
in the last step of the gradient. The flow rate was 0.5 mL/min, the
injection volume was 10 &#956;L, and the column temperature was set
at 25 &#176;C. The DAD monitored the spectrum range of 190&#8211;600
nm, and chromatograms at 280 and 340 nm were directly obtained.</p><p>The chromatographic system was coupled to a Bruker Esquire 3000 plus
IT mass spectrometer equipped with an ESI source (Bruker Daltonics
GmbsH, Bremen, Germany). An MS/MS analysis was performed in negative
ionization mode considering the <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> range of 50&#8211;1400. The values of the other parameters were
set as follows: capillary voltage, 2340 nV; dry temperature, 360 &#176;C;
dry gas flow, 9 L/min; nebulizing gas pressure, 45 psi; and fragmentation
amplitude, 0.8 V. Data acquisition was performed with Data Analysis
4.0 software (Bruker Daltonics GmbsH).</p></sec><sec id="sec2.7"><label>2.7</label><title>Identification and Quantification of Metabolites</title><p>The separation of the metabolites was achieved using reversed-phase
HPLC. The identification was performed by interpreting the molecular
mass and product ions obtained by the mass spectrometer, taking into
consideration the information provided from the literature. All MS
results were compared with MS analysis of untreated adipocyte samples
(cellular control) and of the solvents used in sample preparation
(blank, without cellular material). Quantification was performed by
preparing calibration curves with the seven standard compounds. Stock
solutions were prepared at 100 &#956;M in methanol:water (80:20,
v/v) as the cellular samples, and six solutions at different concentrations
were analyzed in triplicate for each standard. Peak areas were obtained
from chromatograms at 340 nm for verbascoside, isoverbascoside, caffeic
acid, ferulic acid, and luteolin-7-diglucuronide, whose linear regression
ranged from 1.5625 to 100 &#956;M. For hydroxytyrosol and homoprotocatechuic
acid, solutions from 3.125 to 100 &#956;M were plotted using chromatograms
at 280 nm. The limit of detection (LOD) and limit of quantification
(LOQ) for each compound were explored with the appropriate dilutions
and estimated based on signal-to-noise ratios of less than 3 and 10,
respectively. The LOD was designated when the metabolite was not observed
in the DAD chromatograms, but traces were detected in the MS analysis.</p></sec><sec id="sec2.8"><label>2.8</label><title>Statistical Analysis</title><p>Statistical
analyses were performed using GraphPad Prism ver. 7.04 (GraphPad Software,
San Diego, CA, USA). The results are expressed as the mean &#177;
standard deviation, unless otherwise indicated. Differences showing <italic toggle="yes">p</italic> &lt; 0.05 were considered statistically significant. One-way
analysis of variance (ANOVA) and Tukey&#8217;s post hoc test for
multiple comparisons were used to assess differences in antioxidant
capacity tests. Additionally, the Pearson coefficient was employed
to assess the correlation between the antioxidant activity of incubated
compounds and the intracellular appearance of their metabolites. Cellular
experiments for antioxidant capacity and chromatographic analysis
were independently performed three times.</p></sec></sec><sec id="sec3"><label>3</label><title>Results and Discussion</title><sec id="sec3.1"><label>3.1</label><title>Antioxidant Effect of Lemon Verbena Metabolites
in Hypertrophic 3T3-L1 Adipocytes</title><p>To evaluate the antioxidant
effect of lemon verbena metabolites on glucotoxicity-induced hypertrophic
3T3-L1 adipocytes, we first aimed to establish the potential contributors
to oxidative stress in this cell model. Mature adipocytes with 10
days of differentiation were induced with 25 mM glucose for an additional
7 days to obtain hypertrophic adipocytes,<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> and the generation of total ROS and superoxide anion (the main initial
form of ROS in cells<sup><xref ref-type="bibr" rid="ref18">18</xref></sup>) was assessed using
fluorescent probes. As expected, long-term incubation with high glucose
significantly induced ROS production, but not through superoxide anion
formation, whose levels significantly increased in both mature and
hypertrophic adipocytes only after induction with pyocyanin, a toxin
released by <italic toggle="yes">Pseudomonas aeruginosa</italic> that
produces a superoxide anion and ROS in the host cell cytoplasm<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Figure S1</ext-link>). In accordance
with this, H<sub>2</sub>O<sub>2</sub> has been proposed as the primary
contributor of ROS in the presence of high glucose in other cell types.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> In addition, the excess of glucose has been
shown to generate ROS in 3T3-L1 adipocytes mainly through nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase 4,<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> the only isoform expressed in adipocytes that primarily
produces H<sub>2</sub>O<sub>2</sub>.<sup><xref ref-type="bibr" rid="ref21">21</xref></sup></p><p>For the reason mentioned above, the effect of lemon verbena metabolites
on glucotoxicity-induced ROS generation in hypertrophic adipocytes
was conveniently assessed throughout this study by using the cell-permeable
probe H<sub>2</sub>DCFDA, which is rapidly oxidized to the fluorescent
2&#8242;,7&#8242;-dichlorofluorescein in the presence of ROS, predominantly
H<sub>2</sub>O<sub>2</sub>. According to the cell count by Hoechst
staining, none of the compounds showed a cytotoxic effect at the tested
concentrations after incubation for 24 h (data not shown). All the
compounds significantly reduced oxidative stress (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>A). Among them, hydroxytyrosol
was the most potent metabolite, reducing ROS levels to approximately
49% at the lowest concentration (25 &#956;M, <italic toggle="yes">p</italic> &lt;
0. 001) and maintaining the inhibitory effect at higher concentrations.</p><fig id="fig2" position="float" orientation="portrait"><label>Figure 2</label><caption><p>Effect
of seven plasma metabolites from lemon verbena on oxidative
stress in hypertrophic 3T3-L1 adipocytes. A) Intracellular ROS levels
measured by H<sub>2</sub>DCFDA staining. The metabolites were added
at 25, 50, and 100 &#956;M for 24 h. * indicates significant differences
between groups (<italic toggle="yes">p</italic> &lt; 0.001). B) MDA content expressed
in nmol of MDA per mg of protein. The metabolites were added at 100
&#956;M for 24 h. * indicates significant differences compared to
untreated hypertrophic adipocytes (<italic toggle="yes">p</italic> &lt; 0.001).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr3" position="float" orientation="portrait" xlink:href="jf3c06309_0002.jpg"/></fig><p>All the other compounds were less effective than
hydroxytyrosol
at reducing oxidative stress and exhibited a similar dose&#8211;response
behavior, reaching a significant ROS reduction from 25 &#956;M with
verbascoside, ferulic acid, homoprotocatechuic acid, and luteolin-7-diglucuronide
(16%, <italic toggle="yes">p</italic> &lt; 0.001; 18%, <italic toggle="yes">p</italic> &lt;
0.001; 13%, <italic toggle="yes">p</italic> &lt; 0.01; and 13%, <italic toggle="yes">p</italic> &lt; 0.05, respectively), from 50 &#956;M with caffeic acid (12%, <italic toggle="yes">p</italic> &lt; 0.05), and from 100 &#956;M with isoverbascoside
(13%, <italic toggle="yes">p</italic> &lt; 0.001). These results confirm that,
in addition to verbascoside, other plasma metabolites from lemon verbena
have antioxidant power and may contribute to the biological activity
of the extract, as previously suggested.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup></p><p>The overproduction of ROS in cells may damage macromolecules
such
as lipids, causing lipid peroxidation.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> To test whether the antioxidant power of lemon verbena metabolites
prevents lipid peroxidation in hypertrophic adipocytes, the cells
were treated with the concentration at which all metabolites significantly
reduced ROS (100 &#956;M) and the content of MDA, the end product
of this oxidative process,<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> was measured.
All metabolites except ferulic acid significantly reduced the content
of this oxidative marker (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>B), suggesting that some polyphenols are effective
antioxidants in lipophilic environments.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup></p></sec><sec id="sec3.2"><label>3.2</label><title>Correlation between Antioxidant Effects and
Uptake of Lemon Verbena Metabolites in Hypertrophic Adipocytes</title><p>To identify the intracellular metabolites responsible for the antioxidant
capacity, we performed a comparative study between the intracellular
ROS decrease and the uptake of lemon verbena metabolites by hypertrophic
adipocytes. Notably, we employed a concentration of 100 &#956;M to
aid in the identification of intracellular metabolites, considering
it as the maximum nontoxic concentration at which the compounds demonstrated
effectiveness. The analytical parameters for the seven compounds monitored
by HPLC-DAD-ESI-IT-MS are summarized in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S1.</ext-link> The chromatograms of the detected intracellular metabolites
are shown in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Figure S2</ext-link>, and the identification,
retention time (RT), molecular mass, main MS/MS products, and quantification
data for each peak are included in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Tables S2&#8211;S8</ext-link>. In addition, the spectra of identified metabolites are shown in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Figures S3&#8211;S9</ext-link>. In the case of verbascoside
and isoverbascoside, metabolites were detected in both the membrane
and cytoplasmic fractions (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S9</ext-link>).</p><sec id="sec3.2.1"><label>3.2.1</label><title>Verbascoside</title><p>Verbascoside is the
primary phenylpropanoid glycoside present in lemon verbena and is
structurally characterized by caffeoyl and hydroxytyrosol moieties
bound to &#946;-glucopyranoside through ester and glycosidic links,
respectively, with rhamnose in sequence (1&#8211;3) to the glucose
molecule (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>a).
When verbascoside was added at 100 &#956;M to hypertrophic adipocytes,
the maximum intracellular concentration of this compound (peak 1, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 623) was reached after 3 h of incubation
(0.765 &#177; 0.027 ng/&#956;g protein) and then declined dramatically
at 12 h, maintaining a concentration of 0.182 &#177; 0.009 ng/&#956;g
at the end of the assay (24 h) (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S2</ext-link>). Conversely,
its isomer isoverbascoside (peak 2, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 623) appeared in the cytoplasm at 0.580 &#177; 0.035 ng/&#956;g
after 3 h of incubation with verbascoside and progressively increased,
reaching a maximum concentration at 24 h (0.850 &#177; 0.026 ng/&#956;g).</p><fig id="fig3" position="float" orientation="portrait"><label>Figure 3</label><caption><p>Cellular
metabolism of verbascoside and its correlation with oxidative
stress. A) Uptake and intracellular metabolism of verbascoside and
its effect on ROS generation in hypertrophic 3T3-L1 adipocytes. Verbascoside
was added at 100 &#956;M for 3, 12, and 24 h of treatment. Different
letters indicate significant differences between groups (<italic toggle="yes">p</italic> &lt; 0.05). B) Scheme of the biotransformation pathways of verbascoside
in the cytoplasm of a hypertrophic adipocyte.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr4" position="float" orientation="portrait" xlink:href="jf3c06309_0003.jpg"/></fig><p>In addition to isoverbascoside, four other intracellular
metabolites
derived from verbascoside were tentatively identified (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S2</ext-link>): three methylated metabolites from
verbascoside and isoverbascoside, which were named methylated verbascoside,
methylated isoverbascoside 1, and methylated isoverbascoside 2 (peaks
3, 4, and 5, respectively, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 637),
whose fragment ions at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 193 confirmed
the methyl position in the caffeoyl moiety,<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> and a methylated isoverbascoside derivative (peak 6, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 720) tentatively proposed as methylated isoverbascoside
diacetate. Although the fragmentation pattern of this metabolite has
not yet been reported, monoacetylated products of verbascoside have
been identified in rat urine and feces, and they are 42 Da heavier
than the parent compound.<sup><xref ref-type="bibr" rid="ref23">23</xref></sup></p><p>Methylated
verbascoside and methylated isoverbascoside 2 appeared
in the cytoplasm at 0.326 &#177; 0.006 and 0.342 &#177; 0.011 ng/&#956;g,
respectively, after 3 h of incubation with the standard and gradually
decreased at the end of the experiment (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S2</ext-link>).
Instead, methylated isoverbascoside 1 was detected below the LOQ at
24 h, and methylated isoverbascoside diacetate, not found at 3 h,
was remarkably present after 12 and 24 h (0.547 &#177; 0.038 and 0.721
&#177; 0.058 ng/&#956;g, respectively). Regarding the antioxidant
effect, the maximum decrease in intracellular ROS levels was observed
after 3 and 12 h of incubation (57 and 55% ROS generation, respectively)
and then the oxidative stress rose slightly at the end of the assay
(67% ROS generation) (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A).</p><p>These data indicate that verbascoside is rapidly
absorbed in adipocytes.
As previously suggested in the human intestinal Caco-2 cell model,<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> verbascoside could cross the cell membrane through
a passive diffusion mechanism but with active efflux probably mediated
by transporters. However, the rapid decrease in the level of verbascoside
in adipocytes may primarily be due to its high metabolism. The results
show that verbascoside extensively isomerizes to isoverbascoside and
that both undergo phase II reactions through the action of catechol-O-methyltransferases
(COMTs) followed by acetyltransferases. It should be noted that methylation
and acetylation increase the hydrophobicity of the metabolites, facilitating
their diffusion through the cell membrane. However, the diacetylated
product accumulated in the cytoplasm, suggesting that its excretion
might depend on some efflux transporters (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B). Consistent with our data, the isomerization,
methylation, and acetylation of verbascoside have been observed in
vivo,<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> suggesting that biotransformation
can occur efficiently in the liver.<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> In
this sense, our data indicate that other cell types, such as adipocytes,
can also metabolize this phenylpropanoid.</p><p>Because verbascoside
was rapidly eliminated in hypertrophic adipocytes,
the exhibited antioxidant effect may be primarily attributed to its
isomer, isoverbascoside, that accumulated in the cytoplasm. This is
consistent with its demonstrated radical scavenger activity.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> The findings of the Pearson correlation analysis
support this idea, where, despite revealing nonsignificant negative
correlations between the reduction in ROS levels and intracellular
metabolites (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S10</ext-link>), isoverbascoside
had the correlation that most closely approached significance (<italic toggle="yes">p</italic> = 0.087). On the other hand, the diacetylated metabolite
seems unlikely to contribute to this effect due to its late appearance.
However, if this compound could exert any biological activity in adipocytes
is unknown and deserves further attention.</p><p>It should be noted
that verbascoside and its derivatives were significantly
present in the membrane fractions (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S9</ext-link>), confirming the reported affinity and distribution of this phenylpropanoid
in lipid membranes.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> In fact, verbascoside
was the most effective preventing lipid peroxidation (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>B), and this effect has been
related to its ability to interact with phospholipid membranes, acting
as a radical scavenger in lipophilic environments.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup></p></sec><sec id="sec3.2.2"><label>3.2.2</label><title>Isoverbascoside</title><p>Isoverbascoside
is a structural isomer of verbascoside, in which the caffeoyl moiety
is bound to &#946;-glucopyranoside through the hydroxyl group of
C6 instead of C4 (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>b). Along with verbascoside, isoverbascoside is the primary
plasma metabolite detected in rats after the ingestion of lemon verbena
extract.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> When incubated at 100 &#956;M
in hypertrophic adipocytes, this compound (peak 2, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 623) achieved its maximum intracellular concentration
at 3 h (1.541 &#177; 0.021 ng/&#956;g) and then diminished slightly,
reaching a concentration of 1.171 &#177; 0.076 ng/&#956;g at the
end of the experiment (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S3</ext-link>).</p><fig id="fig4" position="float" orientation="portrait"><label>Figure 4</label><caption><p>Cellular metabolism of
isoverbascoside and its correlation with
oxidative stress. A) Uptake and intracellular metabolism of isoverbascoside
and its effect on ROS generation in hypertrophic 3T3-L1 adipocytes.
Isoverbascoside was added at 100 &#956;M for 3, 12, and 24 h of treatment.
Different letters indicate significant differences between groups
(<italic toggle="yes">p</italic> &lt; 0.05). B) Scheme of the biotransformation
pathways of isoverbascoside in the cytoplasm of a hypertrophic adipocyte.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr5" position="float" orientation="portrait" xlink:href="jf3c06309_0004.jpg"/></fig><p>In addition, four other intracellular metabolites
from isoverbascoside
were tentatively identified in the cytoplasm of adipocytes: verbascoside
(peak 1, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 623), methylated isoverbascoside
1 (peak 3, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 637), methylated
isoverbascoside 2 (peak 4, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 637)
and methylated isoverbascoside diacetate (peak 5, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 720) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S3</ext-link>). Methylated
isoverbascoside 2 was detected at 0.900 &#177; 0.054 ng/&#956;g after
3 h and gradually decreased throughout the assay, reaching 0.250 &#177;
0.015 ng/&#956;g at 24 h (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S3</ext-link>). In addition,
methylated isoverbascoside diacetate progressively appeared after
12 and 24 h (0.625 &#177; 0.062 and 1.127 &#177; 0.075 ng/&#956;g,
respectively). On the other hand, only traces of verbascoside were
found, and methylated isoverbascoside 1 was detected below the LOQ.</p><p>Regarding the antioxidant effect, isoverbascoside achieved a maximum
reduction in ROS levels after 3 and 12 h (53 and 54% ROS generation,
respectively), increasing oxidative stress at the end of the experiment
(69% ROS generation, <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A). According to the Pearson correlation analyses (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S10</ext-link>), the antioxidant behavior was strongly
correlated to the uptake kinetics of isoverbascoside (<italic toggle="yes">p</italic> = 0.005), suggesting that this compound is the primary intracellular
effector. As reported in hamster lung fibroblast cells,<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> isoverbascoside could reduce oxidative stress
in adipocytes by acting as a radical scavenger but also by modulating
cellular antioxidant enzymes such as superoxide dismutase and catalase.
Additionally, methylated isoverbascoside 2 showed a significant negative
correlation between its intracellular appearance and ROS generation
(<italic toggle="yes">p</italic> = 0.037), implying that this metabolite contributes
to the antioxidant effect of isoverbascoside.</p><p>As also occurred
after incubation with verbascoside, isoverbascoside
is rapidly absorbed by adipocytes in a free form, probably by a passive
diffusion mechanism, and it displays a high affinity for membranes
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S9</ext-link>). Likewise, the biotransformation
reactions (methylation and subsequent diacetylation) and the slow
clearance of this metabolite in the cytoplasm of adipocytes were also
confirmed (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>B). In contrast, isomerization to verbascoside was much less favorable
than that in the inverse direction. This finding may be explained
by the instability of verbascoside under elevated pH values,<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> such as physiological conditions, which underlines
the importance of the tissue environment on the structure and bioactivity
of polyphenols.</p></sec><sec id="sec3.2.3"><label>3.2.3</label><title>Hydroxytyrosol</title><p>Hydroxytyrosol (4-[2-dihydroxyphenyl]ethanol)
(<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>c) is the
major phenolic component found in olive oil, either in the free form
or as a part of the secoiridoid oleuropein, and it has been detected
as a plasma metabolite of lemon verbena, probably derived from the
hydrolysis of glycosidic bonds of verbascoside and isoverbascoside.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> When incubated at 100 &#956;M, hydroxytyrosol
was not detected in the cytoplasm of adipocytes at any time, but three
new metabolites derived from the parent compound were identified and
quantified (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S4</ext-link>): two hydroxytyrosol
glucuronides (peaks 1 and 2, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 329)<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> and homovanillyl alcohol glucuronide
(peak 3, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 343), whose fragment
ion at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 167 confirmed a methoxy
position in the benzene ring of the phenol moiety (homovanillyl alcohol).<sup><xref ref-type="bibr" rid="ref29">29</xref></sup></p><p>First, the two hydroxytyrosol glucuronide
isomers and homovanillyl alcohol glucuronide rapidly appeared in the
cytoplasm at 3 h (0.742 &#177; 0.026, 1.967 &#177; 0.029, and 1.264
&#177; 0.069 ng/&#956;g, respectively). However, both hydroxytyrosol
glucuronides progressively disappeared throughout the experiment,
while homovanillyl alcohol glucuronide accumulated, reaching a concentration
of 2.754 &#177; 0.040 ng/&#956;g at 24 h (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>A, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S4</ext-link>).
Concurrently, oxidative stress diminished with incubation time, reaching
its maximum reduction at the end of the experiment (46% ROS generation, <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>A). In concordance
with this, the Pearson correlation coefficients confirmed a significant
negative correlation between the latter metabolite and the reduction
in ROS levels (<italic toggle="yes">p</italic> = 0.041) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S10</ext-link>).</p><fig id="fig5" position="float" orientation="portrait"><label>Figure 5</label><caption><p>Cellular metabolism of hydroxytyrosol and its correlation
with
oxidative stress. A) Uptake and intracellular metabolism of hydroxytyrosol
and its effect on ROS generation in hypertrophic 3T3-L1 adipocytes.
Hydroxytyrosol was added at 100 &#956;M for 3, 12, and 24 h of treatment.
Different letters indicate significant differences between groups
(<italic toggle="yes">p</italic> &lt; 0.05). B) Scheme of the biotransformation
pathways of hydroxytyrosol in the cytoplasm of a hypertrophic adipocyte.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr6" position="float" orientation="portrait" xlink:href="jf3c06309_0005.jpg"/></fig><p>Despite not detecting hydroxytyrosol in the cytoplasm
of adipocytes,
a previous study in Caco-2 cells demonstrated that this phenylethanoid
crosses the cell membrane via passive diffusion.<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> Since hydroxytyrosol uptake in adipocytes was not evaluated
at incubation times of less than 3 h, we propose that this compound
could rapidly diffuse in free form into the cells and be immediately
conjugated by UDP-glucuronosyltransferases (UGTs) and O-methyltransferases.
Furthermore, the absence of homovanillyl alcohol (methyl hydroxytyrosol)
suggested that the parent compound is preferentially glucuronidated
and subsequently methylated (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>B). According to the above sequence of events, this
metabolic pathway is also predominant in human hepatoma HepG2 cells
after long incubation times.<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> As reported
with several flavonoids,<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> this presence
could occur because hydroxytyrosol induces UGT activity, favoring
its own glucuronidation.</p><p>However, although methylation or glucuronidation
could favor the
excretion of metabolites, homovanillyl alcohol glucuronide accumulated
in the cytoplasm of adipocytes. It has been reported that conjugated
metabolites accumulate in certain tissues and form a metabolite pool
for the release of active metabolites, which could explain this fact;<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> but because no extracellular metabolites were
assessed in this study, further research is needed to clarify the
clearance of this metabolite.</p><p>Data on the in vitro antioxidant
capacity of hydroxytyrosol metabolites
compared to the parent compound are controversial,<sup><xref ref-type="bibr" rid="ref34">34</xref>,<xref ref-type="bibr" rid="ref35">35</xref></sup> probably due to the fact that these metabolites require prior deglucuronidation
to cross the cell membrane and exert their effects, as suggested previously
in rat aorta rings and human red blood cells.<sup><xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref37">37</xref></sup> Consistent with this property, hydroxytyrosol glucuronides have
been shown to exert a comparable ability to that of the parent compound
in protecting renal tubular epithelial cells against membrane oxidative
damage, probably through direct antioxidant action.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup></p><p>Notably, hydroxytyrosol, which is well-known as a
potent radical
scavenger, also induces the expression of glutathione-related antioxidant
enzymes in HepG2 cells by enhancing the nuclear translocation of nuclear
factor erythroid 2-related factor 2 (Nrf2) via phosphatidylinositol-3-kinase
(PI3K)/protein kinase B (AKT) and extracellular signal-regulated kinase
(ERK) pathways.<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> According to this pathway,
we propose that hydroxytyrosol may reverse oxidative stress in hypertrophic
adipocytes through the same mechanism. However, whether glucuronide
derivatives interact with intracellular targets once hydroxytyrosol
is metabolized or, in contrast, whether hydroxytyrosol induces the
cellular antioxidant defense system by interacting extracellularly
with transmembrane receptors requires further research.</p></sec><sec id="sec3.2.4"><label>3.2.4</label><title>Caffeic Acid</title><p>Caffeic acid (3,4-dihydroxycinnamic
acid) (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>d) is
the most common hydroxycinnamic acid found in fruits, vegetables,
cereals, and coffee, primarily as an ester with quinic acid (chlorogenic
acid). Moreover, it represents a plasma metabolite of lemon verbena
derived from the hydrolysis of glycosidic bonds of verbascoside and
isoverbascoside.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> After incubation at 100
&#956;M, caffeic acid (peak 4, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 179) was poorly absorbed by adipocytes, reaching a maximum concentration
of 0.313 &#177; 0.006 ng/&#956;g at 3 h and decreasing throughout
the experiment (0.175 &#177; 0.007 and 0.213 &#177; 0.015 ng/&#956;g
after 12 and 24 h, respectively) (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>A, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S5</ext-link>).
Despite the low intracellular concentration, caffeic acid exhibited
a strong antioxidant effect on adipocytes, reducing oxidative stress
to 55% after 3 and 12 h of incubation and increasing it at the end
of the assay (76% ROS generation) (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>A).</p><fig id="fig6" position="float" orientation="portrait"><label>Figure 6</label><caption><p>Cellular metabolism of caffeic acid and its
correlation with oxidative
stress. A) Uptake of caffeic acid and its effect on ROS generation
in hypertrophic 3T3-L1 adipocytes. Caffeic acid was added at 100 &#956;M
for 3, 12, and 24 h of treatment. Different letters indicate significant
differences between groups (<italic toggle="yes">p</italic> &lt; 0.05). B) Scheme
of the biotransformation pathways of caffeic acid in the cytoplasm
of a hypertrophic adipocyte.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr7" position="float" orientation="portrait" xlink:href="jf3c06309_0006.jpg"/></fig><p>In addition, three new intracellular metabolites
were detected
below the LOD or LOQ (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S5</ext-link>). They were
identified as 3-methoxy caffeic acid 4-O-glucuronide (ferulic acid
glucuronide, peak 1, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 369), caffeic
acid glucuronide (peak 2, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 355),
and 4-methoxy caffeic acid 3-O-glucuronide (isoferulic acid glucuronide,
peak 3, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 369).<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> The fragment ion at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 193 in peaks 1 and 3 corresponded to monohydroxycinnamic acid bearing
a methoxy substituent at position 3 or 4 on the phenyl ring (ferulic
acid or isoferulic acid, respectively), and the fragment ion at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 175 confirmed the glucuronidation at
position 4 or 3. The longest RT of isoferulic acid compared to ferulic
acid<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> allowed us to identify peaks 1 and
3 as ferulic acid glucuronide and isoferulic acid glucuronide, respectively.</p><p>Among the seven lemon verbena metabolites assayed in this study,
caffeic acid was the least absorbed by hypertrophic adipocytes. The
poor absorption of caffeic acid is consistent with previous studies
in Caco-2 and HepG2 cells.<sup><xref ref-type="bibr" rid="ref41">41</xref>,<xref ref-type="bibr" rid="ref42">42</xref></sup> In fact, this hydroxycinnamate
is transported in enterocytes via paracellular diffusion and, to a
lesser extent, by the monocarboxylic acid transporter (MCT).<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> Previous studies have demonstrated that MCT1
and MCT4 are expressed in mouse and human adipocyte cell lines and
that their expression can be induced during differentiation or by
hypoxia or cold exposure,<sup><xref ref-type="bibr" rid="ref43">43</xref>,<xref ref-type="bibr" rid="ref44">44</xref></sup> suggesting a low expression
level in our in vitro model of hypertrophic cells that explains the
poor absorption of caffeic acid. Nevertheless, this characteristic
should be considered with caution and deserves further investigation.</p><p>Caffeic acid was found to be largely intact in the cytoplasm of
adipocytes with only traces of glucuronide and methyl glucuronide
derivatives. Furthermore, the absence of methylated caffeic acid (ferulic
acid) indicated that glucuronidation occurred prior to methylation
(<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>B), as observed
with hydroxytyrosol (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>B). Consistent with our results, caffeic acid accumulates
little in the cytoplasm of HepG2 cells but exhibits a higher rate
of metabolism,<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> probably due to the higher
activity and isoform diversity of phase II drug-metabolizing enzymes
in hepatocytes.<sup><xref ref-type="bibr" rid="ref45">45</xref></sup> Moreover, caffeic acid
has been shown to diminish oxidative stress-induced hepatotoxicity
by enhancing the expression of detoxification enzymes such as heme
oxygenase-1 and glutamate-cysteine ligase via the ERK/Nrf2 pathway.<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> Despite the lack of statistical significance
in the Pearson correlation analysis (<italic toggle="yes">p</italic> = 0.074) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S10</ext-link>), the substantial accumulation of free
caffeic acid in the cytoplasm suggests that this metabolite is the
intracellular effector responsible for reducing ROS in hypertrophic
adipocytes, probably acting as a direct radical scavenger<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> but also modulating the ERK/Nrf2 pathway.</p></sec><sec id="sec3.2.5"><label>3.2.5</label><title>Ferulic Acid</title><p>Ferulic acid (4-hydroxy-3-methoxycinnamic
acid) (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>e),
along with caffeic acid, is an abundant hydroxycinnamic acid in foods
and has been detected as a plasma metabolite of lemon verbena, probably
from the 3-O-methylation of the caffeic acid moiety after the hydrolysis
of glycosidic bonds of verbascoside and isoverbascoside.<sup><xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref47">47</xref></sup> When ferulic acid was added to adipocytes at 100 &#956;M, the maximum
intracellular concentration of this compound (peak 3, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 193) was reached after 3 h of incubation (0.570
&#177; 0.022 ng/&#956;g) and then slightly decreased, accumulating
0.461 &#177; 0.010 ng/&#956;g at 24 h (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>A, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S6</ext-link>).
Moreover, the antioxidant behavior was correlated with the intracellular
accumulation of ferulic acid, showing the lowest ROS levels at 3 and
12 h (62 and 67% ROS generation, respectively) and increasing throughout
the experiment (82% ROS generation at 24 h, <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>A).</p><fig id="fig7" position="float" orientation="portrait"><label>Figure 7</label><caption><p>Cellular metabolism of ferulic acid and its
correlation with oxidative
stress. A) Uptake of ferulic acid and its effect on ROS generation
in hypertrophic 3T3-L1 adipocytes. Ferulic acid was added at 100 &#956;M
for 3, 12, and 24 h of treatment. Different letters indicate significant
differences between groups (<italic toggle="yes">p</italic> &lt; 0.05). B) Scheme
of the biotransformation pathways of ferulic acid in the cytoplasm
of a hypertrophic adipocyte.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr8" position="float" orientation="portrait" xlink:href="jf3c06309_0007.jpg"/></fig><p>In addition, two new metabolites below the LOD
or LOQ were detected
in the cytoplasm of adipocytes after incubation with ferulic acid
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S6</ext-link>): unknown (peak 1, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 500) and ferulic acid glucuronide (peak 2, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 369). The moderate uptake and metabolism
of ferulic acid are consistent with those reported in in vitro hepatic
and colonic epithelium models,<sup><xref ref-type="bibr" rid="ref41">41</xref>,<xref ref-type="bibr" rid="ref48">48</xref></sup> in which glucuronidation
was the primary metabolic transformation of this hydroxycinnamate.
Our data also indicate that ferulic acid is more extensively absorbed
than caffeic acid, as observed in HepG2 cells.<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> Previously, MCT was reported to mediate the transepithelial
transport of ferulic acid,<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> as is the
case for caffeic acid,<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> but with a higher
affinity due to the presence of the methoxy substituent.<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> Likewise, another study has shown that ferulic
acid is mostly transported by passive diffusion in the colonic epithelium,<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> a mechanism that is facilitated by the higher
hydrophobicity of this compound compared to caffeic acid (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>B).</p><p>According
to our data, free ferulic acid was the predominant form
that accumulated in the cytoplasm of adipocytes, indicating that it
acts as the intracellular effector responsible for decreasing glucotoxicity-induced
oxidative stress. This observation is further supported by the Pearson
correlation coefficient (<italic toggle="yes">p</italic> = 0.032) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S10</ext-link>). As in the case of many polyphenols,
the specific mechanism of the antioxidant effect of ferulic acid seems
to be complex since it is able to scavenge free radicals, enhance
antioxidant enzymes, and inhibit pro-oxidant enzymes.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> In this regard, ferulic acid suppressed ROS generation
in rat vascular smooth muscle cells exposed to H<sub>2</sub>O<sub>2</sub> by increasing the activity of antioxidant enzymes (superoxide
dismutase, catalase, and glutathione peroxidase) and inhibiting the
expression and activity of NADPH oxidase.<sup><xref ref-type="bibr" rid="ref52">52</xref></sup></p></sec><sec id="sec3.2.6"><label>3.2.6</label><title>Homoprotocatechuic Acid</title><p>Homoprotocatechuic
acid (3,4-dihydroxyphenylacetic acid, DOPAC) (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>f) is a neuronal metabolite of dopamine but
is also produced through the metabolism of certain phenolic acids
and flavonoids in the gastrointestinal tract. It has been identified
in rat plasma after lemon verbena ingestion,<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> probably through the biotransformation of caffeic acid or hydroxytyrosol.<sup><xref ref-type="bibr" rid="ref53">53</xref>,<xref ref-type="bibr" rid="ref54">54</xref></sup> When added at 100 &#956;M to hypertrophic adipocytes, homoprotocatechuic
acid (peak 1, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 167)<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> was detected intracellularly at 0.288 &#177;
0.039 ng/&#956;g after 3 h of incubation; it reached its maximum
concentration (0.342 &#177; 0.015 ng/&#956;g) at 12 h and decreased
to a final concentration of 0.187 &#177; 0.006 ng/&#956;g at the
end of the assay (<xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>A, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S7</ext-link>). Concurrently, intracellular
ROS levels decreased strongly at 3 and 12 h (59% and 66% ROS generation,
respectively), restoring with the clearance of homoprotocatechuic
acid at 24 h (82% ROS generation, <xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>A).</p><fig id="fig8" position="float" orientation="portrait"><label>Figure 8</label><caption><p>Cellular metabolism of homoprotocatechuic acid
and its correlation
with oxidative stress. A) Uptake and intracellular metabolism of homoprotocatechuic
acid and its effect on ROS generation in hypertrophic 3T3-L1 adipocytes.
Homoprotocatechuic acid was added at 100 &#956;M for 3, 12, and 24
h of treatment. Different letters indicate significant differences
between groups (<italic toggle="yes">p</italic> &lt; 0.05). B) Scheme of the biotransformation
pathways of homoprotocatechuic acid in the cytoplasm of a hypertrophic
adipocyte.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr9" position="float" orientation="portrait" xlink:href="jf3c06309_0008.jpg"/></fig><p>In addition, a new intracellular metabolite tentatively
identified
as homoveratric acid (3,4-dimethoxyphenylacetic acid, peak 2, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 195)<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> appeared
after incubation with homoprotocatechuic acid, reaching a concentration
of 0.095 &#177; 0.005 ng/&#956;g at 24 h (<xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>A, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S7</ext-link>).
These data indicate that homoprotocatechuic acid is poorly absorbed
and accumulated in adipocytes, similar to caffeic acid (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>A). To our knowledge, this
is the first time that the cellular uptake of homoprotocatechuic acid
has been explored, but the structural similarity to that of caffeic
acid suggests that its influx transport could require the involvement
of some transporters.<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> Once in the cytoplasm,
homoprotocatechuic acid was slowly metabolized to homoveratric acid,
suggesting that methylation is the primary clearance pathway for this
phenolic acid in adipocytes (<xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>B).</p><p>In addition, the decrease in ROS generation
might be exclusively
attributed to homoprotocatechuic acid since the ROS levels increased
with the clearance of this compound, as evidenced by the Pearson correlation
coefficient (<italic toggle="yes">p</italic> = 0.028) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S10</ext-link>). In this context, other authors have shown that homoprotocatechuic
acid is a catabolite from quercetin glycosides that acts as a free
radical scavenger but also as an indirect antioxidant by inducing
phase II detoxification gene expression, such as glutathione <italic toggle="yes">S</italic>-transferase.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> Moreover, the
presence of homoveratric acid in adipocytes did not contribute to
the antioxidant activity. It is proposed that the methylation of both
free 3- and 4-hydroxyl groups eliminates the chemical antioxidant
capacity of the parent compound, consistent with a previous study
in which 3,4-dimethoxycaffeic acid (caffeic acid without its hydroxyl
groups) exhibited very little antioxidant capacity compared to caffeic
acid or ferulic acid (monomethylated caffeic acid).<sup><xref ref-type="bibr" rid="ref57">57</xref></sup></p></sec><sec id="sec3.2.7"><label>3.2.7</label><title>Luteolin-7-diglucuronide</title><p>Luteolin-7-diglucuronide
(luteolin-7-O-[&#946;-glucuronosyl(1&#8594;2)-&#946;-glucuronide])
(<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>g) is present
in lemon verbena extract and represents one of the primary flavone
derivatives detected in rat plasma after the ingestion of the extract,
which may appear through the absorption of the intact compound in
the gut or after its hydrolysis to luteolin and subsequent conjugation
to diglucuronide during its passage through the enterocytes.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> When incubated at 100 &#956;M in hypertrophic
adipocytes, luteolin-7-diglucuronide (peak 1, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 637)<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> appeared rapidly in
the cytoplasm, reaching a concentration of 1.350 &#177; 0.038 ng/&#956;g
after 3 h that was maintained until the end of the assay (<xref rid="fig9" ref-type="fig">Figure <xref rid="fig9" ref-type="fig">9</xref></xref>A, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S8</ext-link>).</p><fig id="fig9" position="float" orientation="portrait"><label>Figure 9</label><caption><p>Cellular metabolism of luteolin-7-diglucuronide and its
correlation
with oxidative stress. A) Uptake and intracellular metabolism of luteolin-7-diglucuronide
and its effect on ROS generation in hypertrophic 3T3-L1 adipocytes.
Luteolin-7-diglucuronide was added at 100 &#956;M for 3, 12, and
24 h of treatment. Different letters indicate significant differences
between groups (<italic toggle="yes">p</italic> &lt; 0.05). B) Scheme of the biotransformation
pathways of luteolin-7-diglucuronide in the cytoplasm of a hypertrophic
adipocyte.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr10" position="float" orientation="portrait" xlink:href="jf3c06309_0009.jpg"/></fig><p>Furthermore, three new intracellular metabolites
were tentatively
identified after incubating with the standard (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S8</ext-link>): two isomers of methylated luteolin-7-diglucuronide
(peaks 2 and 3, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 651), whose
fragment ions at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 299 may correspond
to chrysoeriol (3&#8242;-O-methyl luteolin) or diosmetin (4&#8242;-O-methyl
luteolin),<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> and luteolin-7-glucuronide
(peak 4, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 461).<sup><xref ref-type="bibr" rid="ref60">60</xref></sup> After 3 h, the two methylated isomers appeared in the cytoplasm
at 0.292 &#177; 0.004 and 0.283 &#177; 0.021 ng/&#956;g and luteolin-7-glucuronide
was detected at 0.188 + 0.012 ng/&#956;g. As with the parent compound,
the concentrations of the new metabolites were constant throughout
the experiment (<xref rid="fig9" ref-type="fig">Figure <xref rid="fig9" ref-type="fig">9</xref></xref>A,<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S8</ext-link>). Regarding the antioxidant
effect, the maximum decrease in intracellular ROS levels was observed
after 3 and 12 h (58 and 62% ROS generation, respectively), and then
oxidative stress increased slightly at the end of the assay (75% ROS
generation) (<xref rid="fig9" ref-type="fig">Figure <xref rid="fig9" ref-type="fig">9</xref></xref>A).</p><p>Due to the high polarity of glucuronide conjugates, the
rapid intracellular
appearance of luteolin-7-diglucuronide suggests the existence of a
transporter that mediates the entry of this compound into the cell.
In this regard, several transporters for flavonoids have been previously
described.<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> In particular, two members
of the organic anion transporting polypeptide (OATP) family (i.e.,
OATP1B1 and 1B3) have been shown to actively take up luteolin-3&#8242;-glucuronide
in liver cells.<sup><xref ref-type="bibr" rid="ref62">62</xref></sup> Additionally, the transport
of other flavonoid glucuronides, such as quercetin-3-glucuronide and
quercetin-7-glucuronide, has been proposed to occur through an unidentified
transporter similar to OATP2.<sup><xref ref-type="bibr" rid="ref63">63</xref></sup> However,
flavonoid transporters have not yet been discovered in adipocytes.</p><p>Although the biotransformation of luteolin-7-diglucuronide is unknown,
its aglycone luteolin has been shown to undergo extensive metabolism
in vivo. Luteolin monoglucuronides and methylated luteolin glucuronides
have been found in rat plasma after the administration of luteolin.<sup><xref ref-type="bibr" rid="ref64">64</xref></sup> Our data show that luteolin-7-diglucuronide
is also subject to the action of COMTs in adipocytes, yielding chrysoeriol-7-diglucuronide
and diosmetin-7-diglucuronide. In addition, the formation of luteolin
monoglucuronide suggests the presence of &#946;-glucuronidase activity
in these cells (<xref rid="fig9" ref-type="fig">Figure <xref rid="fig9" ref-type="fig">9</xref></xref>B). This enzymatic activity was also observed in hypertrophic 3T3-L1
adipocytes after incubation with quercetin-3-glucuronide<sup><xref ref-type="bibr" rid="ref65">65</xref></sup> and seemed to be enhanced under certain conditions
of cell damage, as occurs in inflammation.<sup><xref ref-type="bibr" rid="ref66">66</xref></sup></p><p>Furthermore, no clearance of luteolin metabolites was observed
during the incubation time of this experiment, suggesting an inhibition
of efflux transporters. Some flavonoids can act as the potent inhibitors
of efflux transporters, such as breast cancer resistance protein (BCRP).<sup><xref ref-type="bibr" rid="ref67">67</xref></sup> Indeed, BCRP inhibition has been shown to reduce
the excretion of luteolin monoglucuronides, favoring the formation
of diglucuronide in HeLa cells overexpressing UGT1A9.<sup><xref ref-type="bibr" rid="ref68">68</xref></sup> However, further research should be conducted to clarify
the specific mechanism underlying the cellular excretion of luteolin
glucuronides.</p><p>Based on the Pearson correlation coefficients
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">Table S10</ext-link>), the intracellular concentrations
of luteolin-7-diglucuronide
and its methylated isomers (1 and 2) exhibited a negative correlation
with ROS levels (<italic toggle="yes">p</italic> = 0.042, <italic toggle="yes">p</italic> =
0.037 and <italic toggle="yes">p</italic> = 0.043, respectively). Considering that
luteolin-7-diglucuronide was the predominant intracellular metabolite
in hypertrophic adipocytes, it is proposed to be the primary responsible
for the decrease in ROS generation, with a modest contribution from
its methylated metabolites. The in vitro antioxidant capacity of this
flavonoid diglucuronide has been previously reported,<sup><xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref69">69</xref></sup> but little is known about its pharmacological activity in vivo.
Other authors have shown cardioprotective effects in mice,<sup><xref ref-type="bibr" rid="ref70">70</xref></sup> proposing that the prevention of isoproterenol-induced
myocardial injury and fibrosis is due, in part, to the reduction of
ROS generation by inhibiting the expression of NADPH oxidase subunits
in the heart. Considering this, luteolin-7-diglucuronide emerges as
a potential protective agent against oxidative-stress-associated metabolic
disorders.</p><p>The overall results indicate that phenolic metabolites
from lemon
verbena are rapidly absorbed in free form by hypertrophic 3T3-L1 adipocytes
and undergo phase II and, to a lesser extent, phase I reactions probably
through the action of methyltransferase, UGT, acetylase, and &#946;-glucuronidase
enzymes. In particular, verbascoside, isoverbascoside, hydroxytyrosol,
and luteolin-7-diglucuronide are absorbed more extensively than phenolic
acids, which probably favors their higher intracellular metabolism.
In addition, glucuronide conjugations seem to be predominant on phenylethanoids
and phenolic acids, while polyphenols with more complex structures
are preferentially methylated. Accordingly, these metabolites, either
in free form or as conjugated metabolites, are intracellular effectors
that decrease glucotoxicity-induced oxidative stress. We propose that
isoverbascoside, homovanillyl alcohol glucuronide, caffeic acid, ferulic
acid, homoprotocatechuic acid, and luteolin-7-diglucuronide are the
final effectors that exert these antioxidant effects, probably as
radical scavengers or interacting with antioxidant enzymes in hypertrophic
adipocytes. It should be noted that the antioxidant effect exhibited
by the seven metabolites evaluated was maintained, even after 24 h.
Although the concentrations of the major metabolites found in plasma
of rats after the ingestion of lemon verbena extract are within the
nanomolar range,<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> it is postulated that
the slow clearance of these metabolites in cells might favor their
intracellular accumulation and, consequently, their long-term antioxidant
effects in tissues. This is particularly relevant for the formulation
of dietary supplements, as they are intended for daily consumption
to ensure effectiveness.</p><p>In conclusion, these data provide evidence
of how the bioactivity
of polyphenols depends on their uptake, metabolism, and accumulation
in target cells. In particular, these results offer a better understanding
of their potential molecular mechanisms and, consequently, of the
therapeutic effect of lemon verbena in ameliorating obesity-induced
oxidative stress.</p></sec></sec></sec></body><back><notes id="notes1" notes-type="si"><title>Supporting Information Available</title><p>The Supporting Information is
available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acs.jafc.3c06309?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jafc.3c06309</ext-link>.<list id="silist1" list-type="simple"><list-item><p>Supplementary materials and methods; effect of glucotoxicity
on oxidative stress in hypertrophic 3T3-L1 adipocytes (Figure S1);
linear regression data, LOD, and LOQ of the standard compounds monitored
by DAD (Table S1); representative chromatograms of the intracellular
metabolites detected by HPLC-DAD-ESI-IT-MS in hypertrophic adipocytes
(Figure S2); quantification of intracellular metabolites characterized
by HPLC-DAD-ESI-IT-MS in negative mode after incubation with verbascoside,
isoverbascoside, hydroxytyrosol, caffeic acid, ferulic acid, homoprotocatechuic
acid, and luteolin-7-diglucuronide in hypertrophic 3T3-L1 adipocytes
(Tables S2&#8211;S8, respectively); MS spectra of intracellular metabolites
described in Tables S2&#8211;S8 (Figures S3&#8211;S9, respectively);
concentration of intracellular metabolites in the membrane fractions
after incubation with verbascoside or isoverbascoside in hypertrophic
3T3-L1 adipocytes (Table S9). Pearson correlation coefficients between
the ROS levels exhibited in hypertrophic 3T3-L1 adipocytes after incubation
with the seven lemon verbena compounds and the concentration of their
intracellular metabolites over time (Table S10) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jafc.3c06309/suppl_file/jf3c06309_si_001.pdf">PDF</ext-link>)</p></list-item></list></p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jf3c06309_si_001.pdf" position="float" orientation="portrait"><caption><p>jf3c06309_si_001.pdf</p></caption></media></supplementary-material></sec><notes notes-type="" id="notes4"><title>Author Contributions</title><p><sup>&#167;</sup> M.H.-L. and V.M. share co-senior authorship. M.O.-V.,
M.H.-L.,
and V.M. contributed to conceptualization; M.O.-V., N.S.-M., and M.H.-L.
contributed to methodology; M.O.-V. and N.S.-M. contributed to software;
M.O.-V. and N.S.-M. contributed to validation; M.O.-V. and N.S.-M.
contributed to formal analysis; M.O.-V. and N.S.-M. contributed to
investigation; V.M. contributed to resources; M.O.-V. and N.S.-M.
contributed to data curation; M.O.-V. contributed to writing&#8212;original
draft preparation; N.S.-M., M.H.-L., and V.M. contributed to writing&#8212;review
and editing; M.O.-V. and M.H.-L. contributed to visualization; M.H.-L.
and V.M. contributed to supervision; M.H.-L. and V.M. contributed
to project administration; M.H.-L. and V.M contributed to funding
acquisition. All the authors have read and agreed to the published
version of the manuscript.</p></notes><notes notes-type="funding-statement" id="notes3"><p>This research
was funded by the Spanish Ministry of Economy and
Competitiveness (PID2021&#8211;125188OB-C32), Generalitat Valenciana
(PROMETEO/2021/059), and CIBER (CB12/03/30038, Fisiopatologia de la
Obesidad y la Nutricion, CIBERobn, Instituto de Salud Carlos III).
M.H.-L. has also been supported by the Requalification of the Spanish
University System for 2021/2023 grant (Next Generation). PLANTAGING
Project of the &#8220;Programa de Ayudas para la Investigaci&#243;n
del Envejecimiento de la Fundaci&#243;n ICAR, call 2023&#8221;.</p></notes><notes notes-type="COI-statement" id="notes2"><p>The authors
declare no competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>We thank NUTRAFUR, SL for providing us with the
raw materials.</p></ack><glossary id="dl1"><def-list><title>Abbreviations:</title><def-item><term>BCRP</term><def><p>breast
cancer resistance protein</p></def></def-item><def-item><term>COMT</term><def><p>catechol-O-methyltransferase</p></def></def-item><def-item><term>DMEM</term><def><p>Dulbecco&#8217;s modified Eagle&#8217;s
medium</p></def></def-item><def-item><term>DMSO</term><def><p>dimethyl
sulfoxide</p></def></def-item><def-item><term>H<sub>2</sub>DCFDA</term><def><p>2&#8242;,7&#8242;-dichlorodihydrofluorescein
diacetate</p></def></def-item><def-item><term>H<sub>2</sub>O<sub>2</sub></term><def><p>hydrogen
peroxide</p></def></def-item><def-item><term>HPLC-DAD-ESI-IT-MS</term><def><p>high-performance
liquid chromatography with a diode array detector coupled to electrospray
ion trap mass spectrometry</p></def></def-item><def-item><term>IBMX</term><def><p>3-isobutyl-1-methylxanthine</p></def></def-item><def-item><term>LOD</term><def><p>limit of detection</p></def></def-item><def-item><term>LOQ</term><def><p>limit of quantification</p></def></def-item><def-item><term>MCT</term><def><p>monocarboxylic acid transporter</p></def></def-item><def-item><term>MDA</term><def><p>malondialdehyde</p></def></def-item><def-item><term>NADPH</term><def><p>nicotinamide
adenine dinucleotide
phosphate</p></def></def-item><def-item><term>Nrf2</term><def><p>nuclear
factor erythroid 2-related
factor 2</p></def></def-item><def-item><term>OATP</term><def><p>organic
anion transporting polypeptide</p></def></def-item><def-item><term>PBS,</term><def><p>phosphate-buffered saline</p></def></def-item><def-item><term>ROS</term><def><p>reactive oxygen species</p></def></def-item><def-item><term>RT</term><def><p>retention time</p></def></def-item><def-item><term>TBA</term><def><p>thiobarbituric acid</p></def></def-item><def-item><term>UGT</term><def><p>UDP-glucuronosyltransferases</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name name-style="western"><surname>Hussain</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Tan</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Yin</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Blachier</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Tossou</surname><given-names>M. C.</given-names></name>; <name name-style="western"><surname>Rahu</surname><given-names>N.</given-names></name><article-title>Oxidative
Stress and Inflammation: What Polyphenols Can Do for Us?</article-title>. <source>Oxid. Med. Cell. Longevity</source><year>2016</year>, <volume>2016</volume>, <fpage>7432797</fpage><pub-id pub-id-type="doi">10.1155/2016/7432797</pub-id>.<pub-id pub-id-type="pmcid">PMC5055983</pub-id><pub-id pub-id-type="pmid">27738491</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name name-style="western"><surname>Sanchez-Marzo</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Lozano-Sanchez</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Cadiz-Gurrea</surname><given-names>M. L.</given-names></name>; <name name-style="western"><surname>Herranz-Lopez</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Micol</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Segura-Carretero</surname><given-names>A.</given-names></name><article-title>Relationships
Between Chemical Structure
and Antioxidant Activity of Isolated Phytocompounds from Lemon Verbena</article-title>. <source>Antioxidants</source><year>2019</year>, <volume>8</volume>, <fpage>324</fpage><pub-id pub-id-type="doi">10.3390/antiox8080324</pub-id>.<pub-id pub-id-type="pmid">31434276</pub-id><pub-id pub-id-type="pmcid">PMC6719922</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name name-style="western"><surname>Quirantes-Pine</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Herranz-Lopez</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Funes</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Borras-Linares</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Micol</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Segura-Carretero</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Fernandez-Gutierrez</surname><given-names>A.</given-names></name><article-title>Phenylpropanoids
and their metabolites are the major compounds responsible for blood-cell
protection against oxidative stress after administration of Lippia
citriodora in rats</article-title>. <source>Phytomedicine</source><year>2013</year>, <volume>20</volume> (<issue>12</issue>), <fpage>1112</fpage>&#8211;<lpage>1118</lpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2013.05.007</pub-id>.<pub-id pub-id-type="pmid">23827667</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name name-style="western"><surname>Herranz-Lopez</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Barrajon-Catalan</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Segura-Carretero</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Menendez</surname><given-names>J. A.</given-names></name>; <name name-style="western"><surname>Joven</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Micol</surname><given-names>V.</given-names></name><article-title>Lemon verbena (Lippia citriodora) polyphenols alleviate obesity-related
disturbances in hypertrophic adipocytes through AMPK-dependent mechanisms</article-title>. <source>Phytomedicine</source><year>2015</year>, <volume>22</volume> (<issue>6</issue>), <fpage>605</fpage>&#8211;<lpage>614</lpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2015.03.015</pub-id>.<pub-id pub-id-type="pmid">26055125</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name name-style="western"><surname>Carrera-Quintanar</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Funes</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Herranz-Lopez</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Martinez-Peinado</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Pascual-Garcia</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Sempere</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Boix-Castejon</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Cordova</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Pons</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Micol</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Roche</surname><given-names>E.</given-names></name><article-title>Antioxidant
Supplementation Modulates Neutrophil Inflammatory Response to Exercise-Induced
Stress</article-title>. <source>Antioxidants</source><year>2020</year>, <volume>9</volume> (<issue>12</issue>), <fpage>1242</fpage><pub-id pub-id-type="doi">10.3390/antiox9121242</pub-id>.<pub-id pub-id-type="pmid">33297363</pub-id><pub-id pub-id-type="pmcid">PMC7762299</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name name-style="western"><surname>C&#225;diz-Gurrea</surname><given-names>M. D. L. L.</given-names></name>; <name name-style="western"><surname>Olivares-Vicente</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Herranz-L&#243;pez</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Rom&#225;n-Arr&#225;ez</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Fern&#225;ndez-Arroyo</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Micol</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Segura-Carretero</surname><given-names>A.</given-names></name><article-title>Bioassay-guided purification of Lippia
citriodora polyphenols with AMPK modulatory activity</article-title>. <source>J. Funct. Foods</source><year>2018</year>, <volume>46</volume>, <fpage>514</fpage>&#8211;<lpage>520</lpage>. <pub-id pub-id-type="doi">10.1016/j.jff.2018.05.026</pub-id>.</mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name name-style="western"><surname>Funes</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Fern&#225;ndez-Arroyo</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Laporta</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Pons</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Roche</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Segura-Carretero</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Fern&#225;ndez-Guti&#233;rrez</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Micol</surname><given-names>V.</given-names></name><article-title>Correlation between
plasma antioxidant capacity and verbascoside
levels in rats after oral administration of lemon verbena extract</article-title>. <source>Food Chem.</source><year>2009</year>, <volume>117</volume> (<issue>4</issue>), <fpage>589</fpage>&#8211;<lpage>598</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2009.04.059</pub-id>.</mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name name-style="western"><surname>Olivares-Vicente</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Sanchez-Marzo</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Encinar</surname><given-names>J. A.</given-names></name>; <name name-style="western"><surname>de la Luz Cadiz-Gurrea</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Lozano-Sanchez</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Segura-Carretero</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Arraez-Roman</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Riva</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Barrajon-Catalan</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Herranz-Lopez</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Micol</surname><given-names>V.</given-names></name><article-title>The Potential Synergistic Modulation
of AMPK by Lippia citriodora
Compounds as a Target in Metabolic Disorders</article-title>. <source>Nutrients</source><year>2019</year>, <volume>11</volume> (<issue>12</issue>), <fpage>2961</fpage><pub-id pub-id-type="doi">10.3390/nu11122961</pub-id>.<pub-id pub-id-type="pmid">31817196</pub-id><pub-id pub-id-type="pmcid">PMC6950112</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name name-style="western"><surname>Olivares-Vicente</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Barrajon-Catalan</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Herranz-Lopez</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Segura-Carretero</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Joven</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Encinar</surname><given-names>J. A.</given-names></name>; <name name-style="western"><surname>Micol</surname><given-names>V.</given-names></name><article-title>Plant-Derived Polyphenols
in Human Health: Biological Activity, Metabolites and Putative Molecular
Targets</article-title>. <source>Curr. Drug Metab.</source><year>2018</year>, <volume>19</volume> (<issue>4</issue>), <fpage>351</fpage>&#8211;<lpage>369</lpage>. <pub-id pub-id-type="doi">10.2174/1389200219666180220095236</pub-id>.<pub-id pub-id-type="pmid">29468962</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name name-style="western"><surname>L&#243;pez
de las Hazas</surname><given-names>M. C.</given-names></name>; <name name-style="western"><surname>Pi&#241;ol</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Maci&#224;</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Romero</surname><given-names>M. P.</given-names></name>; <name name-style="western"><surname>Pedret</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Sol&#224;</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Rubi&#243;</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Motilva</surname><given-names>M. J.</given-names></name><article-title>Differential absorption and metabolism
of hydroxytyrosol and its precursors oleuropein and secoiridoids</article-title>. <source>J. Funct. Foods</source><year>2016</year>, <volume>22</volume>, <fpage>52</fpage>&#8211;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.jff.2016.01.030</pub-id>.</mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name name-style="western"><surname>Martin</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Ramos</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Granado-Serrano</surname><given-names>A. B.</given-names></name>; <name name-style="western"><surname>Rodriguez-Ramiro</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Trujillo</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Bravo</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Goya</surname><given-names>L.</given-names></name><article-title>Hydroxytyrosol
induces
antioxidant/detoxificant enzymes and Nrf2 translocation via extracellular
regulated kinases and phosphatidylinositol-3-kinase/protein kinase
B pathways in HepG2 cells</article-title>. <source>Mol. Nutr. Food Res.</source><year>2010</year>, <volume>54</volume> (<issue>7</issue>), <fpage>956</fpage>&#8211;<lpage>966</lpage>. <pub-id pub-id-type="doi">10.1002/mnfr.200900159</pub-id>.<pub-id pub-id-type="pmid">20166143</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name name-style="western"><surname>G&#252;l&#231;in</surname><given-names>I.</given-names></name><article-title>Antioxidant
activity of caffeic acid (3,4-dihydroxycinnamic acid)</article-title>. <source>Toxicology</source><year>2006</year>, <volume>217</volume> (<issue>2</issue>), <fpage>213</fpage>&#8211;<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1016/j.tox.2005.09.011</pub-id>.<pub-id pub-id-type="pmid">16243424</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name name-style="western"><surname>Tang</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Nakashima</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Saiki</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Myoi</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Abe</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Kuwazuru</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Zhu</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Ashida</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Murata</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Nakamura</surname><given-names>Y.</given-names></name><article-title>3,4-Dihydroxyphenylacetic acid is a predominant biologically-active
catabolite of quercetin glycosides</article-title>. <source>Food Res.
Int.</source><year>2016</year>, <volume>89</volume>, <fpage>716</fpage>&#8211;<lpage>723</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodres.2016.09.034</pub-id>.<pub-id pub-id-type="pmid">28460970</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name name-style="western"><surname>Kuppusamy</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Ilavenil</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Hwang</surname><given-names>I. H.</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Choi</surname><given-names>K. C.</given-names></name><article-title>Ferulic
Acid Stimulates Adipocyte-Specific Secretory Proteins to Regulate
Adipose Homeostasis in 3T3-L1 Adipocytes</article-title>. <source>Molecules</source><year>2021</year>, <volume>26</volume> (<issue>7</issue>), <fpage>7</fpage><pub-id pub-id-type="doi">10.3390/molecules26071984</pub-id>.<pub-id pub-id-type="pmcid">PMC8037266</pub-id><pub-id pub-id-type="pmid">33915783</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name name-style="western"><surname>Herranz-Lopez</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Olivares-Vicente</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Rodriguez Gallego</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Encinar</surname><given-names>J. A.</given-names></name>; <name name-style="western"><surname>Perez-Sanchez</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Ruiz-Torres</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Joven</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Roche</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Micol</surname><given-names>V.</given-names></name><article-title>Quercetin
metabolites from Hibiscus sabdariffa contribute to alleviate glucolipotoxicity-induced
metabolic stress in vitro</article-title>. <source>Food Chem. Toxicol.</source><year>2020</year>, <volume>144</volume>, <fpage>111606</fpage><pub-id pub-id-type="doi">10.1016/j.fct.2020.111606</pub-id>.<pub-id pub-id-type="pmid">32738368</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name name-style="western"><surname>Peir&#243;</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Lafuente</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Matesanz</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Cercas</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Llergo</surname><given-names>J. L.</given-names></name>; <name name-style="western"><surname>Vallejo</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Rodr&#237;guez-
Ma&#241;Ma&#241;As</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>S&#225;nchez-Ferrer</surname><given-names>C. F.</given-names></name><article-title>High glucose
induces cell death of
cultured human aortic smooth muscle cells through the formation of
hydrogen peroxide</article-title>. <source>Br. J. Pharmacol.</source><year>2001</year>, <volume>133</volume> (<issue>7</issue>), <fpage>967</fpage>&#8211;<lpage>974</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjp.0704184</pub-id>.<pub-id pub-id-type="pmid">11487505</pub-id><pub-id pub-id-type="pmcid">PMC1572888</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name name-style="western"><surname>Tsikas</surname><given-names>D.</given-names></name><article-title>Assessment
of lipid peroxidation by measuring malondialdehyde (MDA) and relatives
in biological samples: Analytical and biological challenges</article-title>. <source>Anal. Biochem.</source><year>2017</year>, <volume>524</volume>, <fpage>13</fpage>&#8211;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.ab.2016.10.021</pub-id>.<pub-id pub-id-type="pmid">27789233</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name name-style="western"><surname>Andres</surname><given-names>C. M. C.</given-names></name>; <name name-style="western"><surname>Perez de la Lastra</surname><given-names>J.
M.</given-names></name>; <name name-style="western"><surname>Andres Juan</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Plou</surname><given-names>F. J.</given-names></name>; <name name-style="western"><surname>Perez-Lebena</surname><given-names>E.</given-names></name><article-title>Superoxide Anion Chemistry&#8212;Its
Role at the Core of the Innate Immunity</article-title>. <source>Int.
J. Mol. Sci.</source><year>2023</year>, <volume>24</volume> (<issue>3</issue>), <fpage>1841</fpage><pub-id pub-id-type="doi">10.3390/ijms24031841</pub-id>.<pub-id pub-id-type="pmid">36768162</pub-id><pub-id pub-id-type="pmcid">PMC9916283</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name name-style="western"><surname>Manago</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Becker</surname><given-names>K. A.</given-names></name>; <name name-style="western"><surname>Carpinteiro</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Wilker</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Soddemann</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Seitz</surname><given-names>A. P.</given-names></name>; <name name-style="western"><surname>Edwards</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Grassme</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Szabo</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Gulbins</surname><given-names>E.</given-names></name><article-title>Pseudomonas aeruginosa
pyocyanin induces neutrophil
death via mitochondrial reactive oxygen species and mitochondrial
acid sphingomyelinase</article-title>. <source>Antioxid. Redox Signaling</source><year>2015</year>, <volume>22</volume> (<issue>13</issue>), <fpage>1097</fpage>&#8211;<lpage>1110</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2014.5979</pub-id>.<pub-id pub-id-type="pmcid">PMC4403017</pub-id><pub-id pub-id-type="pmid">25686490</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name name-style="western"><surname>Han</surname><given-names>C. Y.</given-names></name>; <name name-style="western"><surname>Umemoto</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Omer</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Den Hartigh</surname><given-names>L. J.</given-names></name>; <name name-style="western"><surname>Chiba</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>LeBoeuf</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Buller</surname><given-names>C. L.</given-names></name>; <name name-style="western"><surname>Sweet</surname><given-names>I. R.</given-names></name>; <name name-style="western"><surname>Pennathur</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Abel</surname><given-names>E. D.</given-names></name>; <name name-style="western"><surname>Chait</surname><given-names>A.</given-names></name><article-title>NADPH oxidase-derived
reactive oxygen species increases expression of monocyte chemotactic
factor genes in cultured adipocytes</article-title>. <source>J. Biol.
Chem.</source><year>2012</year>, <volume>287</volume> (<issue>13</issue>), <fpage>10379</fpage>&#8211;<lpage>10393</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.304998</pub-id>.<pub-id pub-id-type="pmid">22287546</pub-id><pub-id pub-id-type="pmcid">PMC3322984</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name name-style="western"><surname>Vermot</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Petit-Hartlein</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Smith</surname><given-names>S. M. E.</given-names></name>; <name name-style="western"><surname>Fieschi</surname><given-names>F.</given-names></name><article-title>NADPH Oxidases (NOX):
An Overview from Discovery, Molecular Mechanisms to Physiology and
Pathology</article-title>. <source>Antioxidants</source><year>2021</year>, <volume>10</volume> (<issue>6</issue>), <fpage>890</fpage><pub-id pub-id-type="doi">10.3390/antiox10060890</pub-id>.<pub-id pub-id-type="pmid">34205998</pub-id><pub-id pub-id-type="pmcid">PMC8228183</pub-id></mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name name-style="western"><surname>Ayala</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Munoz</surname><given-names>M. F.</given-names></name>; <name name-style="western"><surname>Arguelles</surname><given-names>S.</given-names></name><article-title>Lipid peroxidation: production, metabolism,
and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal</article-title>. <source>Oxid. Med. Cell. Longevity</source><year>2014</year>, <volume>2014</volume>, <fpage>360438</fpage><pub-id pub-id-type="doi">10.1155/2014/360438</pub-id>.<pub-id pub-id-type="pmcid">PMC4066722</pub-id><pub-id pub-id-type="pmid">24999379</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name name-style="western"><surname>Su</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Xu</surname><given-names>Q.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Song</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Feng</surname><given-names>Y.</given-names></name><article-title>New metabolites
of acteoside identified by ultra-performance liquid chromatography/quadrupole-time-of-flight
MS(E) in rat plasma, urine, and feces</article-title>. <source>Fitoterapia</source><year>2016</year>, <volume>112</volume>, <fpage>45</fpage>&#8211;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.fitote.2016.05.004</pub-id>.<pub-id pub-id-type="pmid">27223850</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name name-style="western"><surname>Zhou</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Huang</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Zhong</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Lu</surname><given-names>B.</given-names></name><article-title>Bioaccessibility and
Absorption Mechanism of Phenylethanoid Glycosides
Using Simulated Digestion/Caco-2 Intestinal Cell Models</article-title>. <source>J. Agric. Food Chem.</source><year>2018</year>, <volume>66</volume> (<issue>18</issue>), <fpage>4630</fpage>&#8211;<lpage>4637</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jafc.8b01307</pub-id>.<pub-id pub-id-type="pmid">29687721</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name name-style="western"><surname>Reid</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Juvonen</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Huuskonen</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Lehtonen</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Pasanen</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Lall</surname><given-names>N.</given-names></name><article-title>In Vitro Human Metabolism
and Inhibition Potency of Verbascoside
for CYP Enzymes</article-title>. <source>Molecules</source><year>2019</year>, <volume>24</volume> (<issue>11</issue>), <fpage>2191</fpage><pub-id pub-id-type="doi">10.3390/molecules24112191</pub-id>.<pub-id pub-id-type="pmid">31212689</pub-id><pub-id pub-id-type="pmcid">PMC6600574</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name name-style="western"><surname>Funes</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Laporta</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Cerdan-Calero</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Micol</surname><given-names>V.</given-names></name><article-title>Effects of verbascoside,
a phenylpropanoid glycoside from lemon verbena, on phospholipid model
membranes</article-title>. <source>Chem. Phys. Lipids</source><year>2010</year>, <volume>163</volume> (<issue>2</issue>), <fpage>190</fpage>&#8211;<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1016/j.chemphyslip.2009.11.004</pub-id>.<pub-id pub-id-type="pmid">19925782</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name name-style="western"><surname>Chae</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Kang</surname><given-names>K. A.</given-names></name>; <name name-style="western"><surname>Bu</surname><given-names>H. D.</given-names></name>; <name name-style="western"><surname>Lee</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Seo</surname><given-names>Y. R.</given-names></name>; <name name-style="western"><surname>Hyun</surname><given-names>J. W.</given-names></name>; <name name-style="western"><surname>Kang</surname><given-names>S. S.</given-names></name><article-title>Antioxidant activity
of isoacteoside from Clerodendron trichotomum</article-title>. <source>J. Toxicol. Environ. Health, Part A</source><year>2005</year>, <volume>68</volume> (<issue>5</issue>), <fpage>389</fpage>&#8211;<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1080/15287390590900750</pub-id>.<pub-id pub-id-type="pmid">15799629</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name name-style="western"><surname>D&#8217;Imperio</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Cardinali</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>D&#8217;Antuono</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Linsalata</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Minervini</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Redan</surname><given-names>B. W.</given-names></name>; <name name-style="western"><surname>Ferruzzi</surname><given-names>M. G.</given-names></name><article-title>Stability-activity
of verbascoside, a known antioxidant compound, at different pH conditions</article-title>. <source>Food Res. Int.</source><year>2014</year>, <volume>66</volume>, <fpage>373</fpage>&#8211;<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodres.2014.09.037</pub-id>.</mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name name-style="western"><surname>Rubi&#243;</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Farr&#224;s</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>de La Torre</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Maci&#224;</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Romero</surname><given-names>M.-P.</given-names></name>; <name name-style="western"><surname>Valls</surname><given-names>R. M.</given-names></name>; <name name-style="western"><surname>Sol&#224;</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Farr&#233;</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Fit&#243;</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Motilva</surname><given-names>M.-J.</given-names></name><article-title>Metabolite profiling
of olive oil and thyme phenols after a sustained intake of two phenol-enriched
olive oils by humans: Identification of compliance markers</article-title>. <source>Food Res. Int.</source><year>2014</year>, <volume>65</volume>, <fpage>59</fpage>&#8211;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodres.2014.05.009</pub-id>.</mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name name-style="western"><surname>Manna</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Galletti</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Maisto</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Cucciolla</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>D&#8217;Angelo</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Zappia</surname><given-names>V.</given-names></name><article-title>Transport mechanism and metabolism
of olive oil hydroxytyrosol in Caco-2 cells</article-title>. <source>FEBS Lett.</source><year>2000</year>, <volume>470</volume> (<issue>3</issue>), <fpage>341</fpage>&#8211;<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-5793(00)01350-8</pub-id>.<pub-id pub-id-type="pmid">10745093</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name name-style="western"><surname>Mateos</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Goya</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Bravo</surname><given-names>L.</given-names></name><article-title>Metabolism of the olive
oil phenols
hydroxytyrosol, tyrosol, and hydroxytyrosyl acetate by human hepatoma
HepG2 cells</article-title>. <source>J. Agric. Food Chem.</source><year>2005</year>, <volume>53</volume> (<issue>26</issue>), <fpage>9897</fpage>&#8211;<lpage>9905</lpage>. <pub-id pub-id-type="doi">10.1021/jf051721q</pub-id>.<pub-id pub-id-type="pmid">16366672</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name name-style="western"><surname>Walle</surname><given-names>U. K.</given-names></name>; <name name-style="western"><surname>Walle</surname><given-names>T.</given-names></name><article-title>Induction of human
UDP-glucuronosyltransferase UGT1A1 by flavonoids-structural
requirements</article-title>. <source>Drug Metab. Dispos.</source><year>2002</year>, <volume>30</volume> (<issue>5</issue>), <fpage>564</fpage>&#8211;<lpage>569</lpage>. <pub-id pub-id-type="doi">10.1124/dmd.30.5.564</pub-id>.<pub-id pub-id-type="pmid">11950788</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name name-style="western"><surname>Stevens</surname><given-names>J. F.</given-names></name>; <name name-style="western"><surname>Revel</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Maier</surname><given-names>C. S.</given-names></name><article-title>Mitochondria-Centric
Review of Polyphenol
Bioactivity in Cancer Models</article-title>. <source>Antioxid. Redox
Signaling</source><year>2018</year>, <volume>29</volume> (<issue>16</issue>), <fpage>1589</fpage>&#8211;<lpage>1611</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2017.7404</pub-id>.<pub-id pub-id-type="pmcid">PMC6207154</pub-id><pub-id pub-id-type="pmid">29084444</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name name-style="western"><surname>Tuck</surname><given-names>K. L.</given-names></name>; <name name-style="western"><surname>Hayball</surname><given-names>P. J.</given-names></name>; <name name-style="western"><surname>Stupans</surname><given-names>I.</given-names></name><article-title>Structural characterization of the
metabolites of hydroxytyrosol, the principal phenolic component in
olive oil, in rats</article-title>. <source>J. Agric. Food Chem.</source><year>2002</year>, <volume>50</volume> (<issue>8</issue>), <fpage>2404</fpage>&#8211;<lpage>2409</lpage>. <pub-id pub-id-type="doi">10.1021/jf011264n</pub-id>.<pub-id pub-id-type="pmid">11929304</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name name-style="western"><surname>Khymenets</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Fito</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Tourino</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Munoz-Aguayo</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Pujadas</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Torres</surname><given-names>J. L.</given-names></name>; <name name-style="western"><surname>Joglar</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Farre</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Covas</surname><given-names>M. I.</given-names></name>; <name name-style="western"><surname>de la
Torre</surname><given-names>R.</given-names></name><article-title>Antioxidant activities of hydroxytyrosol
main metabolites do not contribute to beneficial health effects after
olive oil ingestion</article-title>. <source>Drug Metab. Dispos.</source><year>2010</year>, <volume>38</volume> (<issue>9</issue>), <fpage>1417</fpage>&#8211;<lpage>1421</lpage>. <pub-id pub-id-type="doi">10.1124/dmd.110.032821</pub-id>.<pub-id pub-id-type="pmid">20516254</pub-id></mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name name-style="western"><surname>Peyrol</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Meyer</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Obert</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Dangles</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Pechere</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Amiot</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Riva</surname><given-names>C.</given-names></name><article-title>Involvement of bilitranslocase and
beta-glucuronidase in the vascular protection by hydroxytyrosol and
its glucuronide metabolites in oxidative stress conditions</article-title>. <source>J. Nutr. Biochem.</source><year>2018</year>, <volume>51</volume>, <fpage>8</fpage>&#8211;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.jnutbio.2017.09.009</pub-id>.<pub-id pub-id-type="pmid">29078076</pub-id></mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name name-style="western"><surname>Paiva-Martins</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Silva</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Almeida</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Carvalheira</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Serra</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Rodrigues-Borges</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>Fernandes</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Belo</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Santos-Silva</surname><given-names>A.</given-names></name><article-title>Protective activity of hydroxytyrosol
metabolites on erythrocyte oxidative-induced hemolysis</article-title>. <source>J. Agric. Food Chem.</source><year>2013</year>, <volume>61</volume> (<issue>27</issue>), <fpage>6636</fpage>&#8211;<lpage>6642</lpage>. <pub-id pub-id-type="doi">10.1021/jf4016202</pub-id>.<pub-id pub-id-type="pmid">23777263</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name name-style="western"><surname>Deiana</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Incani</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Rosa</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Atzeri</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Loru</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Cabboi</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Paola Melis</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Lucas</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Morales</surname><given-names>J. C.</given-names></name>; <name name-style="western"><surname>Assunta Dessi</surname><given-names>M.</given-names></name><article-title>Hydroxytyrosol
glucuronides protect renal tubular epithelial
cells against H<sub>2</sub>O<sub>2</sub> induced oxidative damage</article-title>. <source>Chem.-Biol. Interact.</source><year>2011</year>, <volume>193</volume> (<issue>3</issue>), <fpage>232</fpage>&#8211;<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbi.2011.07.002</pub-id>.<pub-id pub-id-type="pmid">21798251</pub-id></mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name name-style="western"><surname>Agullo</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Villano</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Garcia-Viguera</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Dominguez-Perles</surname><given-names>R.</given-names></name><article-title>Anthocyanin
Metabolites in Human Urine after the Intake of New Functional Beverages</article-title>. <source>Molecules</source><year>2020</year>, <volume>25</volume> (<issue>2</issue>), <fpage>371</fpage><pub-id pub-id-type="doi">10.3390/molecules25020371</pub-id>.<pub-id pub-id-type="pmid">31963236</pub-id><pub-id pub-id-type="pmcid">PMC7024541</pub-id></mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name name-style="western"><surname>Baj</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Kukula-Koch</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>&#346;wi&#261;tek</surname><given-names>&#321;.</given-names></name>; <name name-style="western"><surname>Zieli&#324;ska-Pisklak</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Adamska-Szewczyk</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Szymczyk</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Rajtar</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Polz-Dacewicz</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Skalicka-Wo&#378;niak</surname><given-names>K.</given-names></name><article-title>Chemical profile, antioxidant activity
and cytotoxic effect of extract from leaves of Erythrochiton brasiliensis
Nees &amp; Mart. from different regions of Europe</article-title>. <source>Open Chem.</source><year>2017</year>, <volume>15</volume> (<issue>1</issue>), <fpage>380</fpage>&#8211;<lpage>388</lpage>. <pub-id pub-id-type="doi">10.1515/chem-2017-0042</pub-id>.</mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name name-style="western"><surname>Mateos</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Goya</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Bravo</surname><given-names>L.</given-names></name><article-title>Uptake and metabolism of hydroxycinnamic
acids (chlorogenic, caffeic, and ferulic acids) by HepG2 cells as
a model of the human liver</article-title>. <source>J. Agric. Food Chem.</source><year>2006</year>, <volume>54</volume> (<issue>23</issue>), <fpage>8724</fpage>&#8211;<lpage>8732</lpage>. <pub-id pub-id-type="doi">10.1021/jf061664g</pub-id>.<pub-id pub-id-type="pmid">17090113</pub-id></mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name name-style="western"><surname>Konishi</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Kobayashi</surname><given-names>S.</given-names></name><article-title>Transepithelial
transport of chlorogenic acid, caffeic
acid, and their colonic metabolites in intestinal caco-2 cell monolayers</article-title>. <source>J. Agric. Food Chem.</source><year>2004</year>, <volume>52</volume> (<issue>9</issue>), <fpage>2518</fpage>&#8211;<lpage>2526</lpage>. <pub-id pub-id-type="doi">10.1021/jf035407c</pub-id>.<pub-id pub-id-type="pmid">15113150</pub-id></mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name name-style="western"><surname>Petersen</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Nielsen</surname><given-names>M. D.</given-names></name>; <name name-style="western"><surname>Andersen</surname><given-names>E. S.</given-names></name>; <name name-style="western"><surname>Basse</surname><given-names>A. L.</given-names></name>; <name name-style="western"><surname>Isidor</surname><given-names>M. S.</given-names></name>; <name name-style="western"><surname>Markussen</surname><given-names>L. K.</given-names></name>; <name name-style="western"><surname>Viuff</surname><given-names>B. M.</given-names></name>; <name name-style="western"><surname>Lambert</surname><given-names>I. H.</given-names></name>; <name name-style="western"><surname>Hansen</surname><given-names>J. B.</given-names></name>; <name name-style="western"><surname>Pedersen</surname><given-names>S. F.</given-names></name><article-title>MCT1 and
MCT4 Expression and Lactate Flux Activity
Increase During White and Brown Adipogenesis and Impact Adipocyte
Metabolism</article-title>. <source>Sci. Rep.</source><year>2017</year>, <volume>7</volume> (<issue>1</issue>), <fpage>13101</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-13298-z</pub-id>.<pub-id pub-id-type="pmid">29026134</pub-id><pub-id pub-id-type="pmcid">PMC5638914</pub-id></mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name name-style="western"><surname>Perez
de Heredia</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Wood</surname><given-names>I. S.</given-names></name>; <name name-style="western"><surname>Trayhurn</surname><given-names>P.</given-names></name><article-title>Hypoxia stimulates
lactate release and modulates monocarboxylate transporter (MCT1, MCT2,
and MCT4) expression in human adipocytes</article-title>. <source>Pfluegers
Arch.</source><year>2010</year>, <volume>459</volume> (<issue>3</issue>), <fpage>509</fpage>&#8211;<lpage>518</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-009-0750-3</pub-id>.<pub-id pub-id-type="pmid">19876643</pub-id></mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name name-style="western"><surname>Rowland</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Miners</surname><given-names>J. O.</given-names></name>; <name name-style="western"><surname>Mackenzie</surname><given-names>P. I.</given-names></name><article-title>The UDP-glucuronosyltransferases:
Their role in drug metabolism and detoxification</article-title>. <source>Int. J. Biochem. Cell Biol.</source><year>2013</year>, <volume>45</volume> (<issue>6</issue>), <fpage>1121</fpage>&#8211;<lpage>1132</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2013.02.019</pub-id>.<pub-id pub-id-type="pmid">23500526</pub-id></mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name name-style="western"><surname>Yang</surname><given-names>S.-Y.</given-names></name>; <name name-style="western"><surname>Pyo</surname><given-names>M. C.</given-names></name>; <name name-style="western"><surname>Nam</surname><given-names>M.-H.</given-names></name>; <name name-style="western"><surname>Lee</surname><given-names>K.-W.</given-names></name><article-title>ERK/Nrf2 pathway
activation by caffeic acid in HepG2 cells alleviates its hepatocellular
damage caused by t-butylhydroperoxide-induced oxidative stress</article-title>. <source>BMC Complementary Altern. Med.</source><year>2019</year>, <volume>19</volume> (<issue>1</issue>), <fpage>139</fpage><pub-id pub-id-type="doi">10.1186/s12906-019-2551-3</pub-id>.<pub-id pub-id-type="pmcid">PMC6585055</pub-id><pub-id pub-id-type="pmid">31221142</pub-id></mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name name-style="western"><surname>Felgines</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Fraisse</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Besson</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Vasson</surname><given-names>M. P.</given-names></name>; <name name-style="western"><surname>Texier</surname><given-names>O.</given-names></name><article-title>Bioavailability
of lemon verbena (Aloysia triphylla) polyphenols in rats: Impact of
colonic inflammation</article-title>. <source>Br. J. Nutr.</source><year>2014</year>, <volume>111</volume> (<issue>10</issue>), <fpage>1773</fpage>&#8211;<lpage>1781</lpage>. <pub-id pub-id-type="doi">10.1017/S0007114514000026</pub-id>.<pub-id pub-id-type="pmid">24513110</pub-id></mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name name-style="western"><surname>Poquet</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Clifford</surname><given-names>M. N.</given-names></name>; <name name-style="western"><surname>Williamson</surname><given-names>G.</given-names></name><article-title>Transport and metabolism of ferulic
acid through the colonic epithelium</article-title>. <source>Drug Metab.
Dispos.</source><year>2008</year>, <volume>36</volume> (<issue>1</issue>), <fpage>190</fpage>&#8211;<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1124/dmd.107.017558</pub-id>.<pub-id pub-id-type="pmid">17954526</pub-id></mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name name-style="western"><surname>Konishi</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Shimizu</surname><given-names>M.</given-names></name><article-title>Transepithelial transport of ferulic acid by monocarboxylic
acid transporter in Caco-2 cell monolayers</article-title>. <source>Biosci., Biotechnol., Biochem.</source><year>2003</year>, <volume>67</volume> (<issue>4</issue>), <fpage>856</fpage>&#8211;<lpage>862</lpage>. <pub-id pub-id-type="doi">10.1271/bbb.67.856</pub-id>.<pub-id pub-id-type="pmid">12784628</pub-id></mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name name-style="western"><surname>Konishi</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Kubo</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Shimizu</surname><given-names>M.</given-names></name><article-title>Structural
Effects of Phenolic Acids
on the Transepithelial Transport of Fluorescein in Caco-2 Cell Monolayers</article-title>. <source>Biosci., Biotechnol., Biochem.</source><year>2003</year>, <volume>67</volume> (<issue>9</issue>), <fpage>2014</fpage>&#8211;<lpage>2017</lpage>. <pub-id pub-id-type="doi">10.1271/bbb.67.2014</pub-id>.<pub-id pub-id-type="pmid">14519994</pub-id></mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name name-style="western"><surname>Zdunska</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Dana</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Kolodziejczak</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Rotsztejn</surname><given-names>H.</given-names></name><article-title>Antioxidant
Properties of Ferulic Acid and Its Possible Application</article-title>. <source>Skin Pharmacol. Physiol.</source><year>2018</year>, <volume>31</volume> (<issue>6</issue>), <fpage>332</fpage>&#8211;<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1159/000491755</pub-id>.<pub-id pub-id-type="pmid">30235459</pub-id></mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name name-style="western"><surname>Cao</surname><given-names>Y. J.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>Y. M.</given-names></name>; <name name-style="western"><surname>Qi</surname><given-names>J. P.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>He</surname><given-names>L. C.</given-names></name><article-title>Ferulic acid inhibits H<sub>2</sub>O<sub>2</sub>-induced oxidative
stress and inflammation in rat vascular smooth muscle cells via inhibition
of the NADPH oxidase and NF-kappaB pathway</article-title>. <source>Int. Immunopharmacol.</source><year>2015</year>, <volume>28</volume> (<issue>2</issue>), <fpage>1018</fpage>&#8211;<lpage>1025</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2015.07.037</pub-id>.<pub-id pub-id-type="pmid">26330101</pub-id></mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name name-style="western"><surname>Dominguez-Perles</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Aunon</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Ferreres</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Gil-Izquierdo</surname><given-names>A.</given-names></name><article-title>Gender differences
in plasma and urine metabolites from Sprague-Dawley rats after oral
administration of normal and high doses of hydroxytyrosol, hydroxytyrosol
acetate, and DOPAC</article-title>. <source>Eur. J. Nutr.</source><year>2017</year>, <volume>56</volume> (<issue>1</issue>), <fpage>215</fpage>&#8211;<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1007/s00394-015-1071-2</pub-id>.<pub-id pub-id-type="pmid">26463517</pub-id></mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal" id="cit54"><name name-style="western"><surname>Gonthier</surname><given-names>M. P.</given-names></name>; <name name-style="western"><surname>Verny</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Besson</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Remesy</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Scalbert</surname><given-names>A.</given-names></name><article-title>Chlorogenic
acid bioavailability largely depends on its metabolism by the gut
microflora in rats</article-title>. <source>J. Nutr.</source><year>2003</year>, <volume>133</volume> (<issue>6</issue>), <fpage>1853</fpage>&#8211;<lpage>1859</lpage>. <pub-id pub-id-type="doi">10.1093/jn/133.6.1853</pub-id>.<pub-id pub-id-type="pmid">12771329</pub-id></mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal" id="cit55"><name name-style="western"><surname>Wu</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Pittman Iii</surname><given-names>H. E.</given-names></name>; <name name-style="western"><surname>Hager</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Hager</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Howard</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Prior</surname><given-names>R. L.</given-names></name><article-title>Phenolic
acids in black raspberry and in the gastrointestinal
tract of pigs following ingestion of black raspberry</article-title>. <source>Mol. Nutr. Food Res.</source><year>2009</year>, <volume>53</volume>, <fpage>S76</fpage>&#8211;<lpage>S84</lpage>. <pub-id pub-id-type="doi">10.1002/mnfr.200800231</pub-id>.<pub-id pub-id-type="pmid">19199287</pub-id></mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal" id="cit56"><name name-style="western"><surname>Jia</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Xiao</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Yang</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Jiang</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Zheng</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Zhao</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Zang</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Zheng</surname><given-names>X.</given-names></name><article-title>The anti-atherosclerotic
effect of tanshinol borneol ester using
fecal metabolomics based on liquid chromatography-mass spectrometry</article-title>. <source>Analyst</source><year>2016</year>, <volume>141</volume> (<issue>3</issue>), <fpage>1112</fpage>&#8211;<lpage>1120</lpage>. <pub-id pub-id-type="doi">10.1039/C5AN01970B</pub-id>.<pub-id pub-id-type="pmid">26689835</pub-id></mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="journal" id="cit57"><name name-style="western"><surname>Deng</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Cooney</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Skinner</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Adaim</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Jensen</surname><given-names>D. J.</given-names></name>; <name name-style="western"><surname>Stevenson</surname><given-names>D. E.</given-names></name><article-title>Methylated
polyphenols are poor &#8243;chemical&#8243;
antioxidants but can still effectively protect cells from hydrogen
peroxide-induced cytotoxicity</article-title>. <source>FEBS Lett.</source><year>2006</year>, <volume>580</volume> (<issue>22</issue>), <fpage>5247</fpage>&#8211;<lpage>5250</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2006.08.051</pub-id>.<pub-id pub-id-type="pmid">16962587</pub-id></mixed-citation></ref><ref id="ref58"><mixed-citation publication-type="journal" id="cit58"><name name-style="western"><surname>Shi</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Wu</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Feng</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Xie</surname><given-names>N.</given-names></name><article-title>Comparative
analysis of three Callicarpa herbs using high performance liquid chromatography
with diode array detector and electrospray ionization-trap mass spectrometry
method</article-title>. <source>J. Pharm. Biomed. Anal.</source><year>2013</year>, <volume>75</volume>, <fpage>239</fpage>&#8211;<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpba.2012.11.038</pub-id>.<pub-id pub-id-type="pmid">23277156</pub-id></mixed-citation></ref><ref id="ref59"><mixed-citation publication-type="journal" id="cit59"><name name-style="western"><surname>Shi</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Pan</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Lu</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Ding</surname><given-names>L.</given-names></name><article-title>An HPLC-MS/MS method for the simultaneous
determination of luteolin and its major metabolites in rat plasma
and its application to a pharmacokinetic study</article-title>. <source>J. Sep. Sci.</source><year>2018</year>, <volume>41</volume> (<issue>20</issue>), <fpage>3830</fpage>&#8211;<lpage>3839</lpage>. <pub-id pub-id-type="doi">10.1002/jssc.201800585</pub-id>.<pub-id pub-id-type="pmid">30101558</pub-id></mixed-citation></ref><ref id="ref60"><mixed-citation publication-type="journal" id="cit60"><name name-style="western"><surname>Yin</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Han</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Tang</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Zhao</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Bi</surname><given-names>K.</given-names></name><article-title>UFLC&#8211;MS/MS method for simultaneous determination of luteolin-7-O-gentiobioside,
luteolin-7-O-&#946;-d-glucoside and luteolin-7-O-&#946;-d-glucuronide
in beagle dog plasma and its application to a pharmacokinetic study
after administration of traditional Chinese medicinal preparation:
Kudiezi injection</article-title>. <source>J. Pharm. Biomed. Anal.</source><year>2013</year>, <volume>72</volume>, <fpage>127</fpage>&#8211;<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpba.2012.09.028</pub-id>.<pub-id pub-id-type="pmid">23146236</pub-id></mixed-citation></ref><ref id="ref61"><mixed-citation publication-type="journal" id="cit61"><name name-style="western"><surname>Passamonti</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Terdoslavich</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Franca</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Vanzo</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Tramer</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Braidot</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Petrussa</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Vianello</surname><given-names>A.</given-names></name><article-title>Bioavailability of
flavonoids: A review of their membrane transport and the function
of bilitranslocase in animal and plant organisms</article-title>. <source>Curr. Drug Metab.</source><year>2009</year>, <volume>10</volume> (<issue>4</issue>), <fpage>369</fpage>&#8211;<lpage>394</lpage>. <pub-id pub-id-type="doi">10.2174/138920009788498950</pub-id>.<pub-id pub-id-type="pmid">19519345</pub-id></mixed-citation></ref><ref id="ref62"><mixed-citation publication-type="journal" id="cit62"><name name-style="western"><surname>Zhi</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Yuan</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Jiang</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Ruan</surname><given-names>J.</given-names></name><article-title>Importance of OATP1B1 and 1B3 in
the Liver Uptake of Luteolin and Its Consequent Glucuronidation Metabolites</article-title>. <source>J. Agric. Food Chem.</source><year>2020</year>, <volume>68</volume> (<issue>7</issue>), <fpage>2063</fpage>&#8211;<lpage>2070</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jafc.9b06954</pub-id>.<pub-id pub-id-type="pmid">32009392</pub-id></mixed-citation></ref><ref id="ref63"><mixed-citation publication-type="journal" id="cit63"><name name-style="western"><surname>O&#8217;Leary</surname><given-names>K. A.</given-names></name>; <name name-style="western"><surname>Day</surname><given-names>A. J.</given-names></name>; <name name-style="western"><surname>Needs</surname><given-names>P. W.</given-names></name>; <name name-style="western"><surname>Mellon</surname><given-names>F. A.</given-names></name>; <name name-style="western"><surname>O&#8217;Brien</surname><given-names>N. M.</given-names></name>; <name name-style="western"><surname>Williamson</surname><given-names>G.</given-names></name><article-title>Metabolism
of quercetin-7- and quercetin-3-glucuronides
by an in vitro hepatic model: the role of human beta-glucuronidase,
sulfotransferase, catechol-O-methyltransferase and multi-resistant
protein 2 (MRP2) in flavonoid metabolism</article-title>. <source>Biochem.
Pharmacol.</source><year>2003</year>, <volume>65</volume> (<issue>3</issue>), <fpage>479</fpage>&#8211;<lpage>491</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-2952(02)01510-1</pub-id>.<pub-id pub-id-type="pmid">12527341</pub-id></mixed-citation></ref><ref id="ref64"><mixed-citation publication-type="journal" id="cit64"><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>Q.</given-names></name>; <name name-style="western"><surname>Zhu</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name>; <name name-style="western"><surname>Zeng</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Lu</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Hu</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>Z.</given-names></name><article-title>Metabolic Disposition
of Luteolin Is Mediated by the Interplay of UDP-Glucuronosyltransferases
and Catechol-O-Methyltransferases in Rats</article-title>. <source>Drug
Metab. Dispos.</source><year>2017</year>, <volume>45</volume> (<issue>3</issue>), <fpage>306</fpage>&#8211;<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1124/dmd.116.073619</pub-id>.<pub-id pub-id-type="pmid">28031430</pub-id><pub-id pub-id-type="pmcid">PMC6041822</pub-id></mixed-citation></ref><ref id="ref65"><mixed-citation publication-type="journal" id="cit65"><name name-style="western"><surname>Herranz-Lopez</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Borras-Linares</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Olivares-Vicente</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Galvez</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Segura-Carretero</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Micol</surname><given-names>V.</given-names></name><article-title>Correlation between the cellular metabolism of quercetin and its
glucuronide metabolite and oxidative stress in hypertrophied 3T3-L1
adipocytes</article-title>. <source>Phytomedicine</source><year>2017</year>, <volume>25</volume>, <fpage>25</fpage>&#8211;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2016.12.008</pub-id>.<pub-id pub-id-type="pmid">28190467</pub-id></mixed-citation></ref><ref id="ref66"><mixed-citation publication-type="journal" id="cit66"><name name-style="western"><surname>Shimoi</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Saka</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Nozawa</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Sato</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Amano</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Nakayama</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Kinae</surname><given-names>N.</given-names></name><article-title>Deglucuronidation
of a flavonoid,
luteolin monoglucuronide, during inflammation</article-title>. <source>Drug Metab. Dispos.</source><year>2001</year>, <volume>29</volume> (<issue>12</issue>), <fpage>1521</fpage>&#8211;<lpage>1524</lpage>.<pub-id pub-id-type="pmid">11717168</pub-id></mixed-citation></ref><ref id="ref67"><mixed-citation publication-type="journal" id="cit67"><name name-style="western"><surname>Pick</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Muller</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Mayer</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Haenisch</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Pajeva</surname><given-names>I. K.</given-names></name>; <name name-style="western"><surname>Weigt</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Bonisch</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Muller</surname><given-names>C. E.</given-names></name>; <name name-style="western"><surname>Wiese</surname><given-names>M.</given-names></name><article-title>Structure-activity
relationships of flavonoids as inhibitors of breast cancer resistance
protein (BCRP)</article-title>. <source>Bioorg. Med. Chem.</source><year>2011</year>, <volume>19</volume> (<issue>6</issue>), <fpage>2090</fpage>&#8211;<lpage>2102</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2010.12.043</pub-id>.<pub-id pub-id-type="pmid">21354800</pub-id></mixed-citation></ref><ref id="ref68"><mixed-citation publication-type="journal" id="cit68"><name name-style="western"><surname>Tang</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>W. Y.</given-names></name>; <name name-style="western"><surname>Zeng</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Dong</surname><given-names>L. N.</given-names></name>; <name name-style="western"><surname>Peng</surname><given-names>X. J.</given-names></name>; <name name-style="western"><surname>Jiang</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Hu</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>Z. Q.</given-names></name><article-title>Breast cancer resistance
protein-mediated efflux of luteolin glucuronides in HeLa cells overexpressing
UDP-glucuronosyltransferase 1A9</article-title>. <source>Pharm. Res.</source><year>2014</year>, <volume>31</volume> (<issue>4</issue>), <fpage>847</fpage>&#8211;<lpage>860</lpage>. <pub-id pub-id-type="doi">10.1007/s11095-013-1207-0</pub-id>.<pub-id pub-id-type="pmid">24092055</pub-id></mixed-citation></ref><ref id="ref69"><mixed-citation publication-type="journal" id="cit69"><name name-style="western"><surname>Hennebelle</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Sahpaz</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Gressier</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Joseph</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Bailleul</surname><given-names>F.</given-names></name><article-title>Antioxidant
and neurosedative properties of polyphenols and iridoids from Lippia
alba</article-title>. <source>Phytother. Res.</source><year>2008</year>, <volume>22</volume> (<issue>2</issue>), <fpage>256</fpage>&#8211;<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.2266</pub-id>.<pub-id pub-id-type="pmid">17705148</pub-id></mixed-citation></ref><ref id="ref70"><mixed-citation publication-type="journal" id="cit70"><name name-style="western"><surname>Ning</surname><given-names>B. B.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Wu</surname><given-names>D. D.</given-names></name>; <name name-style="western"><surname>Cui</surname><given-names>J. G.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>P. W.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>W. J.</given-names></name>; <name name-style="western"><surname>Zhu</surname><given-names>W. L.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>T.</given-names></name><article-title>Luteolin-7-diglucuronide
attenuates isoproterenol-induced myocardial
injury and fibrosis in mice</article-title>. <source>Acta Pharmacol.
Sin.</source><year>2017</year>, <volume>38</volume> (<issue>3</issue>), <fpage>331</fpage>&#8211;<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1038/aps.2016.142</pub-id>.<pub-id pub-id-type="pmid">28112175</pub-id><pub-id pub-id-type="pmcid">PMC5342667</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>